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The extracellular matrix (ECM) is a dynamic environment that provides important 
cues for directing intermediate and terminal cell fate. Cells are able to respond to and 
actively remodel their ECM. This dynamic remodeling of the ECM is essential for 
processes including development, normal tissues homeostasis, as well as wound healing. 
However, many different severe pathologies can arise when ECM remodeling becomes 
uncontrolled. Dysregulation of both the biochemical and biophysical properties of the 
ECM are observed in several diseases including cancer and fibrotic pathologies such as 
cardiovascular disease and pulmonary fibrosis. These changes in the ECM force cell into 
a non-homeostatic niche, altering their normal responses to the microenvironment. In the 
case of pulmonary fibrosis, the ECM is known to shift biochemically from a 
predominantly laminin and elastin matrix to a provisional matrix that is predominantly 
composed of fibrin and fibronectin (Fn). Furthermore, the elasticity of tissue from 
patients with pulmonary fibrosis has been shown to increase approximately nine-fold, 
drastically changing the biophysical properties of the matrix. For example, many studies 
have shown that cells adjust their internal stiffness to match their surroundings in 
response to increases in substrate stiffness. This mechanical homeostasis between the cell 
and its increasingly stiff surrounding environment results in increased activation of 
several contractile signals including Rho and Rho associated kinase (ROCK). This 
increased contractile signaling results in many diverse secondary effects, such as 
increased forces applied by cells to their underlying ECM. As a consequence of increased 
forces on the matrix, proteins that comprise structural proteins, for example Fn, can 
 xvii 
undergo conformational changes including partial unfolding, which further changes the 
biochemical nature of the ECM.  Specifically, changes in the conformation of Fn have 
been shown to have major consequences on cell phenotype and fate by the ability to alter 
integrin binding. These alterations in the ECM as well as changes in mechanical 
properties of the ECM are hypothesized to contribute to pathological processes such as 
epithelial to mesenchymal transition (EMT).  
EMT, the differentiation of cells from an epithelial to mesenchymal phenotype, 
has been highly implicated in several disease including cancer metastasis and the onset 
and progression of pulmonary fibrosis. The process of EMT is necessary for many 
biological processes such as embryonic development and adult wound healing. However, 
when dysregulated, EMT can lead to tissue and organ deficiencies. EMT is a highly 
regulated process that integrates biochemical signals from ECM receptors known as 
integrins as well as growth factor receptors like transforming growth factor – β (TGFβ) 
receptor. TGFβ is of particular interest in the onset and progression of pulmonary fibrosis 
because it has been shown to be a potent inducer of EMT in several different cell types 
and tissues. TGFβ must be activated in order to bind to its receptors. This activation can 
occur through several different mechanisms, including but not limited to a mechanical 
activation process as a result of cell contractile forces. Given that this activation is a cell-
mediated process, mechanical activation of TGFβ will be greatly influences by both the 
aforementioned changes to the biochemical and biophysical properties of the ECM. 
Previous work has shown that increases in substrate stiffness as well as changes in 
integrin engagement can modulate cell contractility, leading to TGFβ activation and 
ultimately EMT.  
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Adding the complexity of studying the mechanisms that contribute to the onset and 
progression of pulmonary fibrosis is the continual exposure of the lung to insults of injury 
from day to day activity. For example, pollution and particulate matter (PM) have been 
linked with adverse pulmonary health effects and increased mortality. Environmental PM 
is capable of depositing in the airways of the pulmonary system, penetrating into the 
alveoli, increasing respiratory distress and exacerbating pre-existing pulmonary 
conditions such as pulmonary fibrosis. Specifically, PM has been shown to have 
secondary effects that can induce cellular damage resulting in additional fibrotic 
remodeling events. This additional remodeling stands to further contribute to biochemical 
and biophysical changes of the surrounding matrix. Previous studies to date have focused 
on either biochemical changes or biophysical changes of the matrix on cell phenotype. In 
addition no studies to date have explored how injury events, e.g. exposure to 
environmental pollutant particulate matter, contributes to pathological processes such as 
EMT. This dissertation seeks to first, connect the biochemical and biophysical changes 
observed in the ECM during fibrosis to the pathologic process of EMT and second, 
determine how exposure to physiologically relevant levels of environmental pollutants 
affects the process of EMT during remodeling events.  
First, the role of alterations in Fn conformation on cell binding and phenotype 
were explored. Recombinant Fn fragments were created that model different 
conformational states of the molecule and integrin specific binding to the fragments as 
well as downstream cell phenotypes were investigated to confirm our model system. 
Next, to explore simultaneous alterations in the biochemical and biophysical properties 
commonly seen during pulmonary fibrosis, a model system was created that utilized the 
 xix 
aforementioned Fn fragments cross-linked to polyacrylamide gels of varying substrate 
stiffnesses mimicking healthy to fibrotic tissue stiffnesses. EMT responses were 
characterized and the role of TGFβ activation was investigated. Finally, the role of 
exposure to PM in conjunction with the established model accounting for biochemical 
and biophysical changes to the microenvironment was explored for EMT responses, 
TGFβ activation, and the presence of reactive oxygen species.  
The results presented here show that both biochemical and biophysical state of the 
ECM contribute to the pathological progression of EMT, and that there is a delicate 
balance between the two. Specifically, the work shows that, biochemical changes which 
facilitate cell binding through α5β1 and α3β1 integrins, can maintain an epithelial 
phenotype, and activate low levels of TGFβ even on stiffer substrates that alone drive 
EMT. Conversely, we show that biochemical changes that facilitate cell binding through 
αv integrins lead to enhanced activation of TGFβ and EMT even on softer substrates that 
alone maintain epithelial phenotype. Furthermore, we find that exposure to environmental 
particulates on intermediate substrate stiffness, modeling a “pre-fibrotic” state, drive 
epithelial cells to completely undergo EMT and activate significantly increased levels of 
TGFβ. In addition, this work shows that a partial recovery of epithelial phenotype and 
decreased levels of TGFβ are observed when cells exposed to PM are cultured in 
conjunction with Fn fragments that force cell binding predominantly through α5β1 and 
α3β1 integrin. Finally, the presence of reactive oxygen species (ROS) was explored, and 
we conclude that the presence of ROS is a possible contributor to the increased levels of 
TGFβ and EMT seen with the addition of PM. These results taken together show that 
there is a delicate balance between both the biochemical and biophysical components of 
 xx 
the ECM, TGFβ, and EMT, that these responses can be altered by exposure to injury 
adjuvants such as PM, and that these changes to the cellular microenvironment can be 
significant contributors to the emergence of pathological phenotypes that are associated 












Fibrosis is a potentially deadly pathology that is characterized by excessive 
deposition of extracellular matrix, which leads to increased stiffness of the tissue and 
ultimately loss of tissue structure and function. Many lung diseases, including pulmonary 
fibrosis, COPD, and lung cancer are thought to be driven by changes in the ECM that 
drive the pathological phenotypes that contribute to the disease. Mounting evidence 
suggests that the lung “precursor” cell, the alveolar type II (ATII) epithelial cell is a key 
player in the initiation and progression of pulmonary fibrosis. Although the exact 
mechanism has yet to be elucidated, it is generally accepted that in response to changes in 
the extracellular environment, altered signaling events result in the ATII cell undergoing 
an epithelial to mesenchymal transition, which leads to secretory fibroblasts, that lay 
down increased matrix and stiffen the lung tissue (1-5).  
 During pulmonary fibrosis, cells experience many changes to their 
microenvironment at both the biochemical and biophysical level, resulting in a stiffer 
underlying ECM (6-12), and a change in the ECM composition from a predominantly 
laminin and elastin matrix to a provisional ECM composed predominantly of fibrin and 
fibronectin (Fn) (13). The mechanisms of the biophysical changes in the matrix have 
been widely studied, and are thought to occur through a combination of changes in the 
ECM composition by means of changes in gene expression, increased glycosylation, and 
increased cross-linking of the matrix through tissue transglutaminases or lysyl oxidase 
(14, 15). Furthermore, much of the cell population in fibrotic tissue has been shown to 
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shift to a more contractile phenotype, which can further contribute to mechanical changes 
in the ECM. This increased contractility of cells further regulates the state of the matrix 
not only by stiffening the surrounding tissue, but also by altering the biochemical state of 
fibrillar ECM proteins, notably Fn (13). Fn is highly sensitive to force-mediated 
unfolding, where only small inputs of force can lead to expansion of the cell binding 
domain, resulting in the separation of the major integrin binding sites, RGD and PHSRN 
(13, 16, 17). The positioning of these two sites is crucial to determining which integrins 
cells use to bind their ECM. Specifically, the relative positioning of these two sites has 
been shown to influence α5β1 integrin binding, resulting in changes in integrin 
engagement based on positioning, and ultimately driving differential cell phenotypes (1, 
18-20).  
 A major process that has been implicated in the onset and progression of 
pulmonary fibrosis is the epithelial to mesenchymal transition (EMT) (2, 21-24). EMT is 
the de-differentiation of an epithelial cell into a mesenchymal cell, and is characterized 
by a loss of cell-cell contacts, decreased expression of epithelial markers such as e-
cadherin, and a loss of cell polarity, while concomitantly gaining increased expression of 
mesenchymal markers such as alpha smooth muscle actin (α-SMA), increased ECM 
production, and an increase in stress fiber formation, cell contractility, and cell mobility 
(25-27) . Several studies have observed EMT in pulmonary fibrosis models. For example, 
in-vivo, in a bleomycin induced pulmonary fibrosis model, EMT was observed within the 
fibrotic regions of the lung (28). In addition, multiple studies in-vitro, have shown that 
ATII cells undergo EMT in response to their exposed underlying matrix. Specifically, 
ATII cells cultured on laminin matrices (Ln) maintain an epithelial phenotype, while 
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ATII cells cultured on provisional Fn matrices undergo EMT (29, 30). Although the exact 
mechanisms which stimulate the onset and progression of EMT are still unclear, it is 
under agreement that transforming growth factor beta (TGFβ) is a major player and a 
potent inducer of EMT (29-37). TGFβ must be activated in order to bind to its 
receptor(s), which can be performed through several different mechanisms including 
specific integrin binding, the presence of reactive oxygen species (ROS), proteolytic 
cleavage, and increases in pH (38-43). In addition, increased cell contractile forces can 
result in a mechanical activation of TGFβ. This increase in cell contractile events can be a 
result of biophysical changes of the matrix, such as increased tissue stiffness, or 
biochemical changes, such as the binding of αv integrin to the altered provisional Fn 
matrix (29, 44-46) .  
 Although it is known that both the biochemical and biophysical properties of the 
ECM have dramatic effects on cell phenotype and the progression of fibrotic pathologies, 
no studies to date have explored how cell phenotype is affected when several different 
dynamic remodeling events occur simultaneously. In addition, the presence and 
activation of TGFβ is a crucial factor shown to be upregulated from both changes in 
biochemical and biophysical nature of the ECM. However, these changes are certainly 
not the only factors which can induce TGFβ activation; notably, studies have shown that 
increased ROS can lead to the activation of TGFβ (39, 47-51). This is of particular 
interest in the initiation and progression of pulmonary diseases due to the continued 
exposure of the lung to insults of injury, including environmental particulate matter (PM). 
Previous studies have shown that particles generated from numerous different sources 
have to ability to cause or exacerbate lung disease and that the fibrogenic potential of 
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these particles is due to a combination of several factors including particle size, surface 
area, and composition (52-56). Smaller inhaled particles, under 10 microns, can reach the 
distal lung and have a higher potential to cause injury due to their high surface to mass 
ratio (57-59). These sized particles are of particular interest in the progression of 
pulmonary fibrosis due to their ability to reach into the alveoli and come in contact with 
the ATII cells. In addition, these particles are likely able to induce an inflammatory 
response in the lung and result in widespread secondary effects (59-61).  
Although it is known that each of these factors is critical during pulmonary 
homeostasis and remodeling, there is little known about how dynamic changes to the 
ECM work together in controlling cell viability and phenotype. Furthermore, no studies 
to date have focused on how environmental injury adjuvants affect the lung during 
notable matrix remodeling events. The overall objective of this thesis was to characterize 
how the biophysical and biochemical nature of the ECM contribute to TGFβ activation 
and subsequently EMT, and how further exposure to injury adjuvants alters this response. 
Specifically, this work aims to explore how the altered cellular environment during the 
initiation and progression of pulmonary fibrosis affects future insults of lung injury. The 
central hypothesis of this work is that both increases in substrate rigidity and changes in 
integrin engagement work together to modulate cell contractility, TGFβ activation and 
subsequently EMT events, and that this process is exacerbated by exposure to 
environmental injury adjuvants. This dissertation explores the combined influence of 
substrate rigidity and integrin specific interactions with or without exposure to 
environmental injury adjuvants, on ATII cell contractility, TGFβ activation, and 
downstream EMT events. Integrin-specific recombinant fragments of Fn type III repeats, 
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specifically the 9th and 10th type III repeats (FnIII9’10), polyacrylamide gels of varying 
rigidity, and different concentrations of isolated PM were used to address this hypothesis 
through two specific aims: 1) Determine the integrated response of ATII cells to 
changing biochemical (integrin specific adhesion domains) and biophysical (matrix 
elasticity) microenvironment cues; and 2) Once the microenvironment has been 
established as dynamic, determine the consequence of additional injurious environmental 
adjuvants on ATII cell phenotype and modulation of EMT. This work will provide 
insight into the pathological progression of pulmonary fibrosis and may uncover potential 
targets for diagnostic tools or therapeutics.  
 
Specific Aim 1: Determine the integrated response of ATII cells to changing 
biochemical (integrin specific adhesion domains) and biophysical (matrix elasticity) 
microenvironment cues 
The hypothesis of this aim was that adhesive ligands that promote α3, but not αv, 
integrin engagement will inhibit epithelial cell contraction in response to higher matrix 
elastic moduli, TGFβ activation, and EMT events. Since α3 and α5 integrins are known 
to play a major role in wound healing while αv integrins are implicated in fibrotic 
progression, a model system of varying Fn fragments that preferentially bind either α3/α5 
integrins or αv integrins was developed. The system was first validated by surface 
plasmon resonance (SPR), cell attachment, and cell spreading studies. In addition, 
increased matrix rigidity was modeled by creating polyacrylamide gels of increasing 
stiffness exhibiting elastic moduli indicative of either healthy or fibrotic tissues. ATII 
cells were cultured on the polyacrylamide gels of varying rigidities with each of the Fn 
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fragments crosslinked to the surface or Fn or Ln coated glass as controls. EMT was 
investigated through western blot and immunofluorescence analysis of various epithelial 
and mesenchymal markers. Cell contractility was investigated through analysis of stress 
fiber formation, and changes in cell phenotype in the presence of the contractility 
inhibitor, Y-27632. Lastly, the role of TGFβ activation in response to changes in the 
biophysical and biochemical properties of the matrix was investigated by the mink lung 
epithelial cell assay.  
 
Specific Aim 2: Once the microenvironment has been established as dynamic, 
determine the consequence of additional injurious environmental adjuvants on ATII 
cell phenotype and modulation of EMT 
 The hypothesis of this aim was that exposure of ATII cells to environmental fine 
particulate matter during altered biochemical and biophysical matrix conditions will 
increase TGFβ activation and exacerbate stiffness mediated EMT events. Fine particulate 
matter (PM2.5) was collected on Teflon filters from the Atlanta area and analyzed for 
major elemental composition. The total PM was isolated from the filters and serial 
dilutions were done to provide three different physiological concentrations indicative of 
high, medium, and low exposure levels. ATII cells were cultured on polyacrylamide gels 
of varying rigidities with Fn cross-linked to the surface or Fn or Ln coated glass as 
controls with or without each of the different levels of PM2.5 and analyzed for cell 
contractility, TGFβ activation, and EMT events. Additionally, ATII cells were cultured as 
described above, but with the FnIII9’10 fragments crosslinked to the polyacrylamide gels 
and TGF β activation analysis was compared. Finally, the presence and contribution of 
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reactive oxygen species was explored by an oxidation assay and TGFβ activation was 
measured in the presence and absence of antioxidants.  
 This body of work focuses on a highly significant unknown in the field of 
pulmonary repair, remodeling, and pathogenesis, by investigating the combined role of 
integrin specific binding, tissue rigidity, and environmental injury exposure in initiating 
and modulating EMT. Studies to date have focused on single changes to the matrix on 
ATII cell phenotypic differentiation; however, the pulmonary microenvironment is highly 
dynamic with many changes occurring simultaneously during pathogenesis. Therefore it 
is imperative to study how these dynamic changes work together in the control of 
pulmonary cell phenotype. Specifically, this study focuses on the role of increases in 
tissue rigidity, over a range of tissue stiffnesses observed in pulmonary fibrosis in-vivo, in 
conjunction with a model of integrin binding that utilizes domains characteristic of either 
healthy or fibrotic lung in exploring ATII cell phenotypic differentiation. Additionally, 
no studies to date have explored how these dynamic changes of the microenvironment are 
altered in response to additional insults of injury. This is highly significant because 
several other epithelial tissues, such as skin, can be isolated from further injury during the 
repair process, whereas the lung is continually exposed to insults of injury. 
Understanding how these processes interact with one another to control alveolar cell 
phenotype will provide insight into how the biochemical and biophysical properties of the 
matrix contribute to the pathological process of pulmonary fibrosis, and how these 
conditions alter the normal repair process of the lung in response to injury, which could 
uncover new potential targets for therapeutics targeted towards halting the progression of 
the disease. This work illustrates the importance of both the biochemical and biophysical 
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properties and signals from the ECM in the pathological progression of EMT. Notably, 
this work shows for the first time that there is a fine balance between the biophysical and 
biochemical properties of the matrix in regulating EMT. Furthermore, this delicate 
balance can be shifted by additional insults of injury characteristic of normal pollutant 
exposure. Current therapeutics for fibrotic diseases widely focus on treating the cells, but 
this work suggests that 1) the state of the matrix based on disease progression must be 
considered, and that 2) combinatorial approaches that control TGFβ activation through 
fine control the matrix properties and decreasing oxidative stress may be an improved 






 Epithelial to Mesenchymal Transition in Lung Fibrosis 
Fibrotic pathologies are characterized by excessive ECM production, interstitial 
scar tissue formation, and an increase in tissue stiffness. During the course of idiopathic 
pulmonary fibrosis (IPF), functional lung tissue of the alveoli is replaced with collagen-
rich ECM, leading to rapid and severe decreases in lung compliance and irreversible loss 
of lung function (62, 63). IPF is a currently untreatable and ultimately fatal condition 
with 3 and 5 year mortality rates of 50% and 80%, respectively (5). In addition to 
formation of scar tissue, another hallmark of IPF and other fibrotic conditions is the 
influx of extremely contractile myofibroblasts. The influx of myofibroblasts further 
perpetuates the disease through persistent matrix production and contraction, contributing 
to increased cytokine activation. Lack of effective treatment options for this disease, and 
many other fibrotic diseases is largely due to lack of understanding of the exact 
mechanisms initiating fibrosis, however many studies implicate alveolar epithelial to 
mesenchymal transitions (EMT) in the onset and progression of fibrosis (30, 32, 36, 64-
66). EMT has been theorized to increase the number of ECM secreting mesenchymal 
cells, and several cell tracking studies have demonstrated that a considerable number of 
myofibroblasts directly arise from the process of EMT (30, 36, 64, 66, 67).  
EMT is the de-differentiation of an epithelial cell into a mesenchymal cell, and is 
defined through the loss of apical-basolateral polarity, loss of tight cell junctions, and a 
marked down-regulation of e-cadherin. These changes are accompanied by a concomitant 
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up-regulation of α -smooth muscle actin (α-SMA), increased stress fiber formation and 
alignment, increased migration through filopodia and lamellopodia formation, and an 
increased synthesis of ECM. EMT is very important during normal cellular processes in 
wound healing, embryogenesis, and development, contributing to wound-closure, 
blastocyst implantation, gastrulation, generation of the neural crest, and palate closure 
(68-70).  Though EMT is an important cellular transition, if not tightly regulated, EMT 
can lead to dysregulated wound healing and scar tissue formation in mature tissues, 
contributing to pathological conditions such as pulmonary fibrosis.  
EMT has been shown to occur in response to several factors such as growth 
factors including transforming growth factor beta (TGFβ), tumor necrosis factor alpha 
(TNFα), epidermal growth factor (EGF), and reactive oxygen species, as well as in 
response to extracellular matrix proteins including fibronectin (Fn) (35, 71-74). The role 
of TGFβ is by far the most well defined of all these factors, and is known to be a potent 
inducer of EMT. TGFβ signaling is quite complex and can activate a number of different 
pathways, including SMAD-dependent and independent pathways (75-77). SMAD 
dependent signaling can lead to Snail1 activation, which plays a role in EMT by down 
regulating e- cadherin expression and up regulating a number of mesenchymal genes 
including α-SMA (78-80). Though many advances have been made in understanding 
factors contributing to EMT, the precise events leading to the initiation of EMT as well as 
how multiple regulators drive or inhibit the process are still unclear. This dissertation 
focuses on the role of dynamic changes of the biochemical and biophysical properties of 
extracellular matrix microenvironment and how these changes regulate cues involved in 
the onset and progression of EMT on ATII cells.  
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Pulmonary Homeostasis and Repair 
Pulmonary remodeling and repair involves a similar process of any epithelial 
barrier, which includes the proliferation, migration, and differentiation of epithelial cells 
into the site of injury in response to provisional ECMs. Specifically, in pulmonary tissue, 
the underlying vasculature is damaged and results in the initiation of the clotting cascade 
and the creation of a fibrin rich intermediate ECM with areas of cross-linked fibronectin. 
This provisional matrix is eventually degraded by invading mesenchymal fibroblasts, and 
then replaced with an intermediate fibronectin rich ECM (81). Alveolar epithelial cells 
then interact with this Fn-rich intermediate ECM, through a range of different ECM-
binding receptors, i.e. integrins. In humans, the program regulating pulmonary 
homeostasis is altered in most pulmonary disease states following injury to the mature 
lung. After injury, the lung epithelium may either activate the necessary repair and 
regeneration pathways as described above for repopulation of the damaged or lost 
epithelial cells, or may undergo an aberrant remodeling and differentiation process, 
which represents the common pathway for many different types of pulmonary diseases 
including emphysema, COPD, and idiopathic interstitial pneumonia. Each of these 
diseases involves defective epithelial-mesenchymal interactions, which lead to 
dysfunctional wound healing and ultimately result in abnormal lung remodeling. The 
events in the pathogenesis of lung disease can be divided into three main phases 
illustrated in Figure 2.1: 1) initiation, resulting from intrinsic and/or extrinsic events that 
cause damage to the epithelium; 2) amplification, mediated in part by the inflammatory 
response; and 3) the response stage, where epithelial cells make a decision to either 
properly repair through activation of proliferative and differentiation programs or 
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reprogram to a dysfunctional differentiation state. This is the critical point where either 
successful healthy repair occurs, or abnormal repair results in the production of a fibrotic 
scar (82). These processes suggest a central role for the alveolar epithelium in disease 





Figure 2.1 The epithelial-mesenchymal wound model for lung injury, repair, and 
regeneration. In the initiation stage, different microinjuries damage and activate alveolar 
epithelial cells. In the amplification stage, activating signals in AEC cells can promote 
release of chemokines/cytokines, promoting migration of inflammatory effector cells into 
the distal lung. Persistent activation can result in apoptosis. In the response stage, repair 
is attempted using local proliferation and transdifferentiation of ATII cells. In the absence 
of successful repair or regeneration, remodeling is initiated. In a fibrotic phenotype (e.g., 
IPF), the local signals (including high TGF-β levels) promotes proliferation of 
fibroblasts, activation of myofibroblasts, increases in basement membrane disruption, 
with resulting formation of a scar (82).  
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TGFβ Activation and Signaling in Pulmonary Repair 
The TGFβ super family consists of a wide range of proteins that are able to 
regulate many different physiological processes including embryonic development, 
homeostasis, wound healing, and cell migration. Cytokines of the TGFβ superfamily are 
dimeric proteins with conserved structures. TGFβ1, 2, and 3 are the prototype of the 
TGFβ superfamily and inhibit proliferation in most cells and can induce apoptosis of 
epithelial cells (34, 43). In addition, these cytokines stimulate mesenchymal cells to 
proliferate and produce ECM and induce a fibrotic response in various tissues in vivo. 
Specifically, TGFβ1 has been shown to play a critical role in the onset and progression of 
EMT in pulmonary tissues. Since TGFβ1 is a potent inducer of EMT and many other 
cellular processes, its presentation needs to be tightly controlled. TGFβ1 exists in an 
inactive form which must be activated in order to bind to its receptor. When TGFβ1 is in 
its inactive form it forms a complex with the latency associated peptide (LAP), named the 
small latent complex. The small latent complex then proceeds to form a large latent 
complex by binding the latent TGFβ binding protein, which allows immobilization of the 
inactive TGFβ in the ECM (83-85). The latent complex of TGFβ is able to be activated in 
the lung through two major possible events. First, activation can occur through integrin 
mediated binding, specifically through binding of the latency-associated protein complex 
to integrin αvβ6 or αvβ8 via RGD sequences (40, 86, 87). Cell contractile forces are 
applied to the integrin-LAP complex and result in a separation of the LAP complex away 
from TGFβ. This allows for either release of the active growth factor in a soluble form 
(αvβ8 engagement) or exposure of it to neighboring cells (αvβ6 engagement) (45, 46). 
Second, activation has been proposed to occur through a similar release process of TGFβ 
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bound within the ECM via the large latent complex (88). Both processes of TGFβ 
activation have been shown to be directly related to biochemical and biophysical changes 
in the extracellular environment, which change integrin expression and induce cell 
contractility. These changes in the environment can then further regulate additional 
activation or inhibition of TGFβ. This dissertation specifically focuses on how dynamic 
changes to both the biochemical and biophysical properties of the ECM commonly 
associated with pulmonary fibrosis work together to control TGFβ activation and 
signaling. 
Inflammation and Pulmonary Fibrosis 
A complex set of reactions must occur for the formation and accumulation of 
fibrous tissue seen in pulmonary fibrosis. Recent evidence has suggested that the 
pathogenesis of pulmonary fibrosis may begin as an inflammatory response to injury 
when immune cells are excessively or improperly activated. These immune cells release 
toxic mediators that compromise epithelial integrity and promote further tissue injury (5, 
62, 63, 66, 89). The repair process involves recruitment of mesenchymal cells, which lay 
down extracellular matrix, re-epithelialization, and restoration of normal lung structure. 
However, aberrant tissue remodeling can occur which results in excessive matrix 
deposition leading to pulmonary fibrosis. Although minimally studied, the inhalation of 
particles that are unable to be cleared from the lungs, may cause a sustained 
inflammatory response that can lead to abnormal tissue remodeling. This tissue 
remodeling may be involved in the initiation and progression of pulmonary disease such 
as pulmonary fibrosis (90).  
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Particles generated from numerous sources have the ability to cause or exacerbate 
lung diseases including asthma, bronchitis, and COPD (89, 91, 92). Fibrotic responses are 
seen in each of these diseases and involve increases in the deposition of extracellular 
matrix by pulmonary fibroblasts. The fibrogenic potential of these particles has been 
shown to be due to several factors including particle size, surface area, and composition. 
Smaller inhaled particles in the 1 to 10 micron range can reach the distal lung, and have a 
higher potential to cause injury due to their high surface to mass ratio (89, 93-95). In 
addition, particle composition is likely an important determinant of the effect of the 
particles on the progression of fibrotic diseases. Both organic and inorganic agents, such 
as transition metals, hydrocarbons, and endotoxins can contribute to the composition of 
particles (94, 96, 97). Previous studies have found that many of the components of the 
particles are able to activate the inflammatory response leading to widespread secondary 
effects. For example, several air pollution sources have been shown to stimulate the 
release of TNFα. Although TNFα does not directly promote fibroblast growth or the 
deposition of ECM proteins, it is able to stimulate the production of TGFβ, a major 
inducer of EMT that leads to the presence of myofibroblasts and subsequent ECM 
deposition commonly seen in pulmonary fibrosis (95, 98-100).  
Reactive Oxygen Species and TGFβ Activation 
Reactive oxygen species (ROS) are small oxygen containing molecules that 
contain a single high-energy electron, giving the molecule strong reactivity and 
contributing to cell signaling pathways and cellular immune defense (101-104). The most 
common ROS are superoxide anions O2-, hydrogen peroxide, and hydroxide radical, HO’ 
(102, 103). ROS can be created and used to signal the presence of acute cellular injury 
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and influence cell function by the activation of TGFβ. Of particular interest in the onset 
and progression of pulmonary fibrosis is that hydroxyl radicals can activate TGFβ by 
direct oxidation of methionine-253 within the LAP peptide. These redox reactions cause 
a rapid conformational change in the LAP, which allows for the rapid release of the 
homodimer. Other isoforms of TGFβ cannot be directly activated by ROS, which makes 
TGFβ1 an interesting sensor of extracellular oxidative stress (39, 48, 50, 51).  
O2- has been implicated in the progression of pulmonary fibrosis. O2- radicals 
have been found to be elevated in the blood of IPF patients, suggesting a deficiency in 
glutathione regulation (51). O2- is able to enter cells through chloride ion receptors in 
lung fibroblasts and leads to the release of active TGFβ and increased collagen and 
fibronectin expression. Interestingly, excessive O2- is known to breakdown into hydroxyl 
radicals, which can activate TGFβ directly in the ECM (105). Interestingly, hydrogen 
peroxide produced by IPF fibroblasts in response to TGFβ signal to alveolar epithelial 
cells to induce apoptosis, which may be an important link to the progression of 
pulmonary fibrosis. Furthermore TGFβ enhanced production of ROS is thought to cause 
a further activation of more TGFβ residing in the tissue by directly activating methionine-
253. This suggests that this redox sensing system of TGFβ causes a positive feedback 
loop resulting in chronic fibrosis (47, 48, 105).  
Approaches targeting ROS, such as treating with high doses of the antioxidant N-
acetyl-cysteine (NAC) have significantly delayed the progression of pulmonary fibrosis 
but do not result in improvements in lung function (93). These outcomes indicate that 
although oxidative stress in the lung is a contributor to the progression of pulmonary 
fibrosis, it is likely that other modes of TGFβ activation contribute to drive fibrogenesis.  
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Alveolar Type II Epithelial (ATII) Cells 
Adult pulmonary tissue is composed of over 40 different cell types and possesses 
over 300 million alveoli, the primary functional structure of lung. Two primary epithelial 
cells populate the alveolus, Type I and II alveolar epithelial cells (ATI and ATII). ATI 
cells, separated from capillaries by only a thin basement membrane, are the primary gas-
exchange cells and comprise 90% of the alveolar surface yet only 10% of the epithelial 
cell number (106, 107). ATII cells are pseudo-cuboidal, multifunctional cells that are 
considered the “protector of the alveolus” due to their central role in defense and repair. 
ATII cells act as the primary surfactant-secreting cell, precursors to ATI cells, and in 
many instances as non- professional antigen-presenting cells (107). ATII cells also 
contribute significantly to the fluid balance across the epithelial barrier through sodium 
transport functions(108). These various functions underscore the vital importance of 
these cells in maintaining pulmonary function. The importance of ATII cells in alveolar 
repair and regeneration is further supported by animal models that show that, in 
bleomycin induced lung injury, intratracheal delivery of a purified population of ATII 
cells is sufficient to block fibrotic lung remodeling. During normal repair, ATII cells are 
thought to proliferate, migrate onto a provisional matrix and differentiate into ATI cells. 
Despite their obvious beneficial effects, evidence has suggested that perturbation or 
repeated injury of ATII cells may result in several undesirable outcomes such as 
increased apoptosis and trasnsdifferentiation to a contractile myofibroblastic phenotype 
resulting in the onset and progression of pathologies such as pulmonary fibrotic disorders 








Figure 2.2 Healthy epithelial pulmonary morphogenesis vs. formation of fibrotic 
tissue. During healthy morphogenesis and repair, ATII precursor cells differentiate into, 
and repopulate ATI cells, fibroblasts repair damaged matrix, and then apoptose, returning 
the environment to a homeostatic state. In dysregulated wound healing, ATII cells 
transdifferentiate into contractile myofibroblasts that secrete excess matrix leading to 
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ATII Cell Integrins 
ATII cells are known to express a wide variety of integrins. There are several 
major integrin pairs expressed in healthy adult ATII cells including α2β1, α3β1, α6β4, 
α9β1, αvβ5, αvβ6, and αvβ8. In addition, α5β1 integrin expression is rapidly increased in 
response to pulmonary injury, and is therefore critical in wound healing responses (112). 
Each of these integrins are known to have critical roles in pulmonary epithelial 
homeostasis, repair, and pathologic responses, including the maintenance of epithelial 
integrity and phenotype (α3β1) (112), regulating wound healing (α5β1) (19), and 
activation of the critical EMT mediator, TGF-β (αvβ6 and αvβ8) (17, 29, 40).  
Many studies have stressed the importance of α3β1 integrin in the maintenance of 
alveolar epithelial integrity. α3β1 integrin expression has regularly been shown to be 
decreased in patients with cancer metastasis and is associated with a more malignant 
phenotype (113). Furthermore, a reduction in α3β1 has also been shown in response to 
TGF β, highly implicating it in the progression of EMT in the lung (114). Typically, 
integrin α3β1 binds laminin as its ligand (112, 115). However, integrin α3β1 has also 
been shown to have the ability to bind other ECM ligands such as collagen and 
fibronectin (116-118). Fibronectin is a provisional matrix protein and is of interest 
because it has the ability to bind many of the integrins that are expressed by ATII cells 
including α3β1, αvβ3, αvβ6, as well as α5β1 during injury (19, 116, 118, 119). The 
binding of α3β1 of Fn has been shown to occur in an RGD dependent manner (119). In 
addition, its binding to Fn can be affected by the presence of α5β1 integrin, notably that 
cells that express comparable levels α3β1 and α5β1 have significantly decreased binding 
of α3β1 (19). This is of particular interest because α5β1 is only expressed in response to 
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injury, indicating that α3β1 likely binds Fn with great affinity under normal, healthy 
conditions. Integrin blocking studies have indicated that α5β1 is the main Fn receptor 
during wound healing, but that α3 blocking antibodies also resulted in significantly 
decreased wound repair (19). These studies highlight that ATII cells have competitive 
binding of these different integrins and that differential binding of these integrins is a 
major factor that drives cell phenotype leading to healthy repair or pathological EMT 
events that result in fibrosis. This work specifically utilizes this fact to create a model 
system where ATII cells will preferentially bind α3/α5 integrins versus αv integrins.  
Biochemical Cues: Fibronectin 
Fibronectin is a soluble dimeric glycoprotein that is composed of two 230-270 
kDa monomers that are linked together covalently by a pair of disulfide bonds 47 56. 
Each of the monomers consists of three repeating modules, names type I, type II, and 
type III. These modules contain functional domains that are able to mediate interactions 
with cell surface receptors, other ECM components, and Fn itself (116). The type I and 
type II repeats are structurally stabilized by two intra-chain disulfide bonds in each 
repeat. Interestingly, the type III repeats have no disulfide bonds subjecting them to be 
highly sensitive to force-mediated unfolding.  
The protein fibronectin is of particular interest in the initiation and progression of 
fibrotic diseases due to its capacity to bind multiple different integrins and initiate many 
different intracellular signals that drive cell phenotype and ultimately the state of the 
tissue. The most studied integrin recognition sequence is the RGD (Arg-Gly-Asp) site, 
which is located on the 10th type III repeat. The recognition of this site is very complex 
and depends of many factors including its three dimensional presentation. For example, 
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binding to RGD along with a second recognition sequence, the synergy site (PHSRN), in 
the adjacent 9th type III repeat is known to promote α5β1 integrin binding to Fn, 
highlighting the importance of these sites in homeostasis vs. wound healing (120-122).  
As previously mentioned these type III repeats are subject to force-mediated 
unfolding, which can lead to changes in integrin engagement and subsequently cell 
phenotype. Due to this elasticity of the 9th and 10th type III repeats, many different 
conformations can arise, resulting in differential integrin specificity in the region (17). Of 
particular interest is the synergy site, which is located on the 9th type III repeat, only 32Å 
from the RGD site on the 10th type III repeat. In this folded conformation, the two sites 
act together to bind α5β1 integrin. However, when exposed to small forces from cells 
(<10 pN) the 10th type III repeat is separated away from the 9th type III repeat. When this 
occurs the distance between these two binding domains are separated by an additional 
20Å (from 32Å to 55Å). This additional separation results in a lack of ability for both 
sites to co-bind a single receptor, and studies have shown that this increased separation 
results in significantly decreased α5β1 integrin binding (123). This is of particular interest 
because it suggests that α5β1 binding can be inhibited by changing the conformation of 
these sites of Fn. In addition, several studies have shown that increasing the stability of 
the 9th and 10th type III repeats modulates integrin accessibility of the RGD site. For 
example, a Leu to Pro point mutation at amino acid 1408, within the 9th type III repeat 
results in increased affinity for α3β1 and α5β1 integrins over αvβ3 integrins (124, 125). 
Numerous studies have highlighted the importance of integrin specificity on cell 
proliferation, differentiation, and ultimate fate. Some examples of this include the 
correlation of αv integrins with increased cell adhesion and proliferation (126, 127), 
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while the β1 subunit has been shown to enhance differentiation (128, 129). Therefore, it 
is clear that changes in the conformation of Fn in diseased state likely has a major impact 
on the integrin specificity with which cells bind, and therefore modulate cell phenotype.  
Biophysical Cues: Mechanics in tissue homeostasis and repair 
The composition of the extracellular matrix surrounding a cell has great 
consequences on cell fate; however, evidence is mounting that, in addition, cells sense 
and respond to the mechanical properties of the ECM, particularly the rigidity of the 
matrix. The process of cellular sensing of the underlying properties of the ECM has been 
termed mechanotransduction. Matrix rigidity has been shown to influence many aspects 
of cellular behavior including stem cell, myoblast, and breast epithelial cell 
differentiation; cellular motility; contractility; and focal adhesion formation, and it has 
also been shown to contribute or prevent a malignant phenotype (6, 7, 9-12, 130-132). 
Previous work has shown that stem cell differentiation can be guided by underlying 
matrix mechanics, with mesenchymal stem cells on hard substrates differentiating down 
an osteoblastic lineage and mesenchymal stem cells on soft substrates differentiating 
down a neuronal lineage, which suggests a potential mechanism through which stem cells 
“match” their differentiation based on the surrounding tissue (7). Interestingly, as 
previously described, changes in tissue rigidity, specifically an increase in rigidity and 
hardening of tissue, is associated with the pathological progression of fibrotic responses. 
Recent atomic force microscopy (AFM) analysis of fibrotic tissue from mice with 
bleomycin-induced pulmonary fibrosis shows a nine-fold increase in rigidity of fibrotic 
tissue compared to that of normal tissue (133). 
Interestingly, it has recently been shown that mesenchymal cells respond to 
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substrate stiffness by engaging their action-myosin contractile machinery in a manner 
that facilitates cell-ECM compliance matching. This has been demonstrated by AFM 
analysis of single cell stiffness, showing fibroblasts become increasingly stiff on 
increasingly rigid substrates, indicating a cell may adjust its internal stress through 
contraction to “match” its external environment (131). As a consequence of this 
mechano-homeostasis between the cell and its ECM, cells in increasingly rigid, or stiff, 
environments display increased activation of contractile signals like Rho and Rho 
associated kinase (ROCK), resulting in multiple and diverse secondary effects. An 
elegant example of this is shown by Wipff et. al. who demonstrate that fibroblast 
activation of TGFβ increases on increasingly rigid substrates, leading to greater 
myofibroblast differentiation on stiff, but not compliant, substrates (45, 46). Because 
fibrotic diseases are characterized by increased tissue rigidity, and because of TGFβ’s 
prominent role in the onset of EMT, we hypothesized that a similar mechanism of 
increased TGFβ activation with increasing rigidity would contribute to EMT on 
increasingly rigid substrates. 
While the precise mechanism of cell rigidity sensing remains still remains 
unclear, it likely involves the transduction of stiffness-mediated signaling via increased 
cell contractility. This dissertation explores the role of mechanotransduction events in the 
onset and progression of EMT by studying the role of biophysical changes of the matrix 
such as substrate rigidity in Fn - mediated EMT. These studies provide insights into the 
role of mechanotransduction in altering the pulmonary microenvironment further and in 
the onset and progression of fibrotic pathologies. 
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CHAPTER 3 
CHARACTERIZATION OF FIBRONECTIN 9-10 VARIANTS: DEVELOPMENT 
OF BIOCHEMICAL MODEL SYSTEM 
 
Introduction 
Cells interact with their surrounding ECM via transmembrane cell surface 
receptors, known as integrins.  Integrins are heterodimeric proteins consisting of one α 
subunit and one β subunit, which are known to form at least 24 unique heterodimers  
(119). Integrin interactions with their extracellular matrix (ECM) ligands facilitate a host 
of cellular responses, including cell spreading, migration, proliferation, and 
differentiation, and can contribute to more orchestrated cellular events, such as 
development and wound healing, by contributing to epithelial to mesenchymal transitions 
(29, 134, 135). Integrin binding to ECM ligands occurs through specific binding 
sequences, the most notable of these sequences being Arg-Gly-Asp (RGD), which is 
found on a large number of ECM proteins, including fibronectin, laminin, and several 
others. (136) Furthermore, integrin heterodimers can interact with multiple ECM ligands 
and bind to multiple binding sequences (137, 138).  
Fibronectin is a widely expressed extracellular matrix protein during epithelial 
tissue repair and regeneration and is known to bind at least 16 integrins.  Biochemically, 
Fn exists as a soluble dimeric glycoprotein composed of two nearly identical 230-270 
kDa monomers linked covalently near their C- termini by a pair of disulfide bonds (116, 
139).  Each monomeric subunit consists of three types of repeating modules, type I, II, 
and III. These modules comprise functional domains that mediate interactions with other 
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ECM components, cell surface receptors, and Fn itself (116). Whereas type I and II 
repeats are structurally stabilized with two intrachain disulfide bonds in each repeat, type 
III repeats have no disulfide bonds and, therefore, are highly sensitive to force-mediated 
unfolding, resulting in alterations of conformation of the molecule (16, 139, 140). This is 
of particular interest in pathological states where cells become more contractile and 
increase their force exerted on the underlying matrix. Interestingly, a large number of Fn-
integrin interactions occur through the RGD site, which is located on the 10th type III 
repeat. The recognition of this simple tripeptide sequence can be quite complex and 
greatly depends on flanking residues, its three dimensional presentation, and individual 
features of the integrin-binding pockets. This is most well characterized in α5β1 integrin 
binding to Fn, in which RGD in combination with a second recognition sequence 
(PHSRN), the so-called “synergy” site, in the adjacent 9th type III repeat is known to 
promote the specific interaction of α5β1 integrin binding to Fn through interactions with 
the α5 subunit (120, 122). The synergy site is located approximately 32 Å from the RGD 
loop on the 10th type III repeat.  The type III repeats show great elasticity in the loops 
between their F- and G-β strands, known as the FG loop, which allows the 9th and 10th 
type III repeats to present multiple conformations.  Under small applied forces (on the 
order of 10 pN) Fn’s 10th type III repeat is susceptible to partial unfolding, resulting in 
an intermediate state in which the RGD loop within the 10th type III repeats begins to 
translocate away from the 9th type III repeat, resulting in an increase in the distance 
between the RGD and synergy sites from approximately 32 Å to approximately 55 Å 
(17).  This capacity to present multiple spatial orientations of the 9th and 10th type III 
repeats has great implications on cell binding and subsequent cell phenotype because the 
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relative positioning of these two domains has been shown to influence integrin α5β1 
binding.  Integrin α5β1 binds by simultaneously engaging the RGD and synergy sites and 
is known to be highly involved in epithelial tissue repair.  As these sites translocate away 
from one another, they can no longer be bound simultaneously, and integrin α5β1 no 
longer binds resulting in changes in the normal tissue repair process. These results 
suggest that the conformation of these two domains may be used to drive which integrins 
cells use to bind Fn. For example, by stabilizing the 9th type III repeat by a Leu-Pro 
mutation at amino acid 1408, there is an increased affinity for α5β1 over integrin αvβ3. 
Alternatively, by increasing the linker region between the RGD and synergy sites there is 
a reduction in α5β1 binding. Furthermore, α3β1 integrin binding to Fn, which is 
associated with epithelial cell homeostasis, may also be promoted by the 9th type III 
repeat  (44).  Using recombinant Fn fragments displaying the RGD and synergy sites with 
a stabilizing (L1408-P) point mutation (FnIII9*10) or RGD alone (FnIII10), it was 
previously demonstrated that the presence of Fn’s synergy site enhances epithelial cell 
integrin specificity; epithelial cell binding to FnIII9*10 was significantly inhibited by 
anti-α3 and anti-α5 antibodies (p<0.01), while their inhibition of cell binding to RGD 
only Fn fragments was negligible. Additionally, epithelial cells seeded on FnIII9*10, but 
not FnIII10, formed α3 and α5 integrin clusters.  
Though the classical ligand for integrin α3β1 is laminin (Ln) (112, 115) it has 
been reported to bind collagen and Fn (116-118) and facilitate cell-cell interactions 
through both homophillic binding and binding to e-cadherin (141-143). Integrin α3β1 
plays a critical role in maintaining epithelial integrity and facilitating wound repair 
responses, and, if not bound to its extracellular matrix ligands, it can contribute to 
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pathologies such as EMT (30, 113). Furthermore, αv integrin engagement has been 
shown to play a major role in the activation of TGF β and the onset and progression of 
EMT. These previous data indicate that stabilization of the synergy and RGD sites on the 
9th and 10th type III repeats increases the specificity for α3 and α5 integrins which are 
associated with healthy tissue and proper repair and regeneration programs. Furthermore, 
these data suggest that separation of these two binding sequences will inhibit α3 and α5 
integrins, and preferentially bind the ECM through αv integrins, which are associated 
with pathological pulmonary conditions.  
Therefore, since integrin binding is highly dependent on the conformation and 
stability of the 9th and 10th type III repeats of Fn, a variety of recombinant FnIII9’10 
variants were created that preferentially bind α3 and α5 integrins or αv integrins. These 
variants display i) a stabilization of the 9th type III repeat by a Leu-Pro mutation at amino 
acid 1408 (9*10), ii) a dominant negative R-A mutation in the synergy site (FnIII9p10), 
iii) a 2xG insertion in the linker region (FnIII92G10), or iv) a 4xG insertion in the linker 
region (FnIII94G10). It was hypothesized that these Fn fragments would display a graded 
loss of affinity for α3 and α5 integrins with increasing decoupling of RGD and synergy 
and display increasing affinity for αv integrins.  First, surface plasmon resonance (SPR) 
was utilized to determine binding kinetics of integrin α3β1, α5β1, and αvβ3 to the Fn 
fragments. Next, cell attachment and cell spreading assays were performed to validate 
differences in cell phenotype based on the differences in integrin binding based on each 




Materials and Methods 
Construction of mutant pGEX4T1-FnIII9-10 clones 
Cloning of the wild type FnIII9-10 was performed as previously described.  A 
Leu1408 to Pro mutation (FnIII9*10) was made using the pGEX4T-1-FN III9-10 plasmid 
as previously described (44, 125, 144).  FnIII9*10 variants displaying i) a dominant 
negative R-A mutation in the synergy site (FnIII9P10), ii) a 2xG insertion in the linker 
region (FnIII92G10), or iii) a 4xG insertion in the linker region (FnIII94G10) were then 
created using the QuikChange® II-E Site-Directed Mutagenesis Kit (Stratagene, La Jolla, 
CA). Sequences are presented in Table 3.1.  All plasmids were introduced to and 
maintained in the electro-competent XL-1 Blue E.coli strain provided and cultured in LB 
+ ampicillin plates at 37°C. Plasmids were extracted from cultures using the QIAquick 
Spin Miniprep Kit (QIAGEN, Valencia, CA) and verified via sequencing (Johns Hopkins 
Synthesis & Sequencing Facility, Baltimore, MD) 
 
 




Fragment Sequence 1373-1423 of FnIII9-10 Role 
FnIII9*10  DRVPHSRNSITLTNLTPGTEYVVSIVALN 
 GREESPPLIGQQSTVSDVRPD 
Leu1408 to Pro; Stabilizes relative positions of 
FnIII9 and FnIII10 
FnIII9P10 DRVPHSANSITLTNLTPGTEYVVSIVALN 
GREESPPLIGQQSTVSDVRPD 
Arg to Ala point mutation in PHSRN site 
FnIII2G10 DRVPHSRNSITLTNLTPGTEYVVSIVALN 
GREESPPLIGQQSTVSGGDVRPD 
Increased distance between FnIII9 and FnIII10 
FnIII4G10 DRVPHSRNSITLTNLTPGTEYVVSIVALN 
GREESPPLIGQQSTVSGGGGDVRPD 
Increased distance between FnIII9 and FnIII10 
 29 
Expression and purification of recombinant FnIII9-10 proteins 
 Recombinant Fn fragments were produced as previously described (44, 144).  
Briefly, the expression vectors described above were transformed into BL21 E.coli, cells 
were grown to the exponential growth phase and treated with IPTG for 3 hours.  Cells 
were then lysed by the addition of 10mg/ml lyzozyme and sonication, followed by  
incubation with 1% triton X-100 and 10U/ml of DNAse I.  Fn fragments were purified by 
GST affinity chromatography (AKTA Purifier, GE Healthcare, Piscataway, NJ, USA).  
GST tags were removed using bovine thrombin (Sigma–Aldrich, St. Louis, MO, USA).  
A second round of purification was performed using GST and serine protease affinity 
chromatography to remove cleaved GST tags and thrombin.  Proteins were verified as 
>98% pure by SDS-PAGE.   
Surface plasmon resonance studies 
The Biacore 2000 (Biacore Lifesciences, GE Healthcare) was used to investigate 
kinetic binding constants (ka and kd) of Fn fragments variants for integrins α3β1, α5β1, 
and αvβ3. Briefly, integrins α3β1, α5β1, or αvβ3 (R&D Systems, Minneapolis, MN, 
USA) were covalently immobilized to gold-coated SPR sensor chips via self-assembled 
monolayer surface chemistry to generate a non-fouling surface with a controlled density 
of reactive carboxylic acid groups. Mixed self-assembled monolayers were generated on 
gold-coated chips as previously described (145, 146) by incubating with a 10:1 mixture 
of 1-mM of tri(ethylene glycol)–terminated alkanethiols (HS-(CH2)11–(OCH2CH2)3–
OH (ProChimia, Gdansk, Poland) and carboxylic acid–terminated alkanethiols (HS-
(CH2)11–(OCH2CH2)6–OCH2COOH) overnight. The sensor chip was then loaded into 
the Biacore 2000 and the carboxylic acid–terminated alkanethiol surfaces was activated 
 30 
by flowing 200mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (Sigma-Aldrich) 
and 50mM N-hydroxysuccinimide (Sigma-Aldrich; 5µL/minute for 10 minutes). 
Immediately after activation, α3β1, α5β1, or αvβ3 integrins (100µg/ml) were 
immobilized at a flow rate of 5µL/minute for 10 minutes to achieve approximately 1500 
resonance units (1 resonance unit ~ 1 pg/mm2).  An additional channel was immobilized 
with BSA to serve as a reference channel; BSA (100ug/ml) was immobilized to achieve 
approximately 1500 resonance units. Immobilization of integrins and BSA were 
performed in 0.1M sodium acetate, pH4.5.  Unreacted N-hydroxysuccinimide groups 
were quenched in all flow cells with 1M ethanolamine, pH 8.5 (10 µL/minute for 10 
minutes). Upon stabilization of the baseline signal, kinetic binding experiments were run 
in duplicate with Fn fragments, full length Fn, or Ln as the flow analytes. Various 
concentrations for each Fn fragment (10µM-1nM) were flowed at 30µL/minute for 5 
minutes immediately followed by a 10-minute dissociation phase. Binding experiments 
were performed in 10mM HEPES, 150mM NaCl, 0.0001% Triton-X 100, and 2mM each 
MgCl2 and MnCl2, pH 7.4.  
SPR analysis and evaluation 
SPR sensorgrams were analyzed with the aid of Scrubber 2 and ClampXP software 
(Center for Biomolecular Interactions Analysis, University of Utah). (147-149) Reference 
cell responses were subtracted from corresponding active response curves. Double-
referenced curves were acquired by further subtracting the reference cell blank buffer 
injections from each reference-subtracted response curve. (150) The resulting curves 
were then analyzed and fitted to the kinetic model. Kinetic modeling and simulations 
were performed with ClampXP software; globally fitted parameters were determined for 
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each kinetic dataset per Fn fragment. Equilibrium binding constants were calculated from 
fitted kinetic constants. Goodness of fit for each model was determined by evaluating the 
residual plots and residual sum of squares. 
Cell spreading and α3β1 integrin binding 
 In order to determine the role of Fn fragments in epithelial cell spreading, RLE-
6TN cells were cultured on FnIII9*10 (2µM), FnIII9P10 (2µM), FnIII92G10 (2µM), 
FnIII94G10 (2µM), Fn (0.1µM), or Ln (0.1µM) coated, hd-BSA blocked coverslips in 
serum-free DMEM/F12 media for 3 hours and fixed with 4% formaldehyde. The 
concentration of Fn was chosen based on previous studies showing similar binding of an 
antibody specific to the 7-10 type III repeats of Fn (clone HFN7.1a1) (144) to Fn coated 
at 0.1µM and the Fn fragments at 2µM concentrations. The concentration of Ln was 
chosen based on ELISAs showing saturation of the surface using 0.1µM.  Cells were 
washed with PBS, fixed with 4% formaldehyde, permeabilized with 0.2% Triton-X 100 
and then blocked with 10% goat serum.  Integrin α3 (Ralph 3.2) antibodies were 
incubated overnight at 4°C then washed thoroughly with PBS + 0.2% Tween-20. 
Secondary antibodies (Alexa-Fluor-488 goat-anti-mouse, Invitrogen; FITC-conjugated 
goat anti-Armenian hamster, Santa-Cruz Biotech) were incubated for 1 hour then washed 
thoroughly with PBS + 0.2% Tween-20.  Actin was stained with Texas-red phalloidin 
(Invitrogen) and nuclei were stained with Hoescht stain (Invitrogen).  Coverslips were 
mounted and images acquired with a Nikon Eclipse (TiE) inverted fluorescence 
microscope at 100X magnification (PlanApo 100X, 1.4 NA oil-immersion objective) 
with a CoolSNAP HQ2 Monochromatic CCD camera.  Representative images are 
presented.   
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 Area and perimeter of individual cells was determined for each condition using 
Image J (NIH Freeware) image processing software, and circularity was determined using 
the equation circularity = 4π(area/perimeter2).   Three independent images were analyzed 
for each condition, and at least 10 cells were analyzed per image.  Data is pooled from all 
3 images analyzed per condition.  Statistical analysis was performed by multi-variate 
ANOVA using Prism (Graphpad Software Inc., La Jolla, CA, USA). Statistical 
significance was achieved for p<0.05.  
Cell attachment assays 
 Wells of a 96 well plate were coated with each of the purified Fn fragments, Fn, or 
Ln overnight at 4°C then blocked with heat denatured BSA. RLE-6TN cells were 
incubated in microcentrifuge tubes at a concentration of 3x106 cells/ ml in DMEM media 
with or without the addition of α3, α5, or αv antibodies or combinations of the three for 
30 minutes at 37°C. In order to determine 100% attachment, RLE-6TN cells were plated 
on poly-L-lysine coated tissue culture plastic wells. Cells with or without the addition of 
antibodies were then plated on each of the Fn fragment, Fn, or Ln coated wells for 30 
min, then all control and treated wells were fixed with 5% gluteraldehyde, and stained 
with 0.1% crystal violet stain. The dye was solubilized in 10% acetic acid and absorbance 
measured on a Biotek Synergy H4 Multi-Mode Plate Reader. Results are pooled from 








Fitted α3β1 binding affinity parameters 
 
SPR with soluble recombinant integrin immobilized to the surface of the sensor 
chip was utilized to determine the role of FnIII9-10 in integrin α3β1 interactions with Fn.  
(Figure 3.1)  
 
                   
 
Figure 3.1: Integrin immobilization:  To analyze integrin binding to FnIII9-10 variants, 
recombinant soluble integrin was immobilized onto a Biacore sensor chip to achieve 




Response curves obtained from all FnIII9-10 variants binding to integrin α3β1 were fit to 
both a 1:1 Langmuir binding model. The fitted parameters ka (“on rate”) and kd, (“off 
rate”), calculated Kd and residual sum of squares of the fit of each FnIII9-10 variant, Fn, 
and Ln using a Langmuir 1:1 model are displayed in Table 3.2 and Figure 3.2.   
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Table 3.2:  Kd values:  α3β1: Langmuir 1:1 model 
  
Comparing kd values obtained from the model, FnIII9*10 was found to have the 
lowest kd of all FnIII9*10 variants analyzed at 7.1 x 10-4 s−1.  Increasing the linker region 
between the 9th and 10th type III repeats with either 2 Gly residues or 4 Gly residues 
resulted in an increase in the kd to 10.8 x 10-4 s−1 and 27.5 x 10-4 s−1, respectively, 
indicating that increasing the space between the PHSRN and RGD sites disrupts the 
interactions between FnIII9-10 domains and integrin α3β1.  Furthermore, an Arg to Ala 
point mutation within the PHSRN site results in an eight-fold increase in kd to 59 x 10-4 
s−1.  Equilibrium dissociation constants, which take kd and ka values into account, were 
calculated for each analyte.  FnIII9’10 was found to have the lowest Kd, 32nM.  Direct 
disruption in the PHSRN site resulted in a fivefold increase in Kd to 172nM, while 
increasing the spacing between the 9th and 10th type III repeats by either 2 or 4 Gly 
residues resulted in a three and 26-fold increase to 97nM and 855nM, respectively.  The 
Kd value for Ln was the lowest for all analytes, 14nM, which was expected, as Ln is 
thought of as the dominant ligand for integrin α3β1; however, Fn was found to have a 
high affinity for the integrin, with a Kd of 24nM.  These results indicate that Fn does bind 
Analyte ka*10-4 kd*104 Kd*109 RSS 
FnIII9*10 4.3+/- 0.3 7.1+/- 0.29 32 1.7 
FnIII9P10 0.49+/- 0.44 59+/- 8.4 172 2.56 
FnIII2G10 1.12+/- 1.12 10.8+/- 5.2 97 2.52 
FnIII4G10 0.311+/- 0.19 27.5+/- 1.7 855 5.85 
Fn 1.0+/- 0.81 2.5+/- 0.9 24 2.5 
Ln 3.47+/- 1.8 4.87+/- 2.46 14 0.223 
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integrin α3β1 with a high affinity, and this binding is dependent on the positioning and 





Figure 3.2: FnIII9-10 variants bound to α3β1, α5β1, and αvβ3. Calculated Kd values 
for FnIII9-10 variants, Fn, and Ln interactions with immobilized α3β1 integrin (A), α5β1 
integrin (B), or αvβ3 integrin (C) were determined using a Langmuir 1:1 model.  
 
 
Kd values for integrins α5β1  
 
The role of the PHSRN site, as well as the relative orientation with respect to the 
RGD site, is known to be critical for α5β1 binding to Fn, while binding to αvβ3 only 
requires the RGD site.  To confirm these previous reports, binding of FnIII9*10, 
FnIII9p10, FnIII92G10, FnIII94G10, Fn, and Ln to immobilized integrin α5β1 and αvβ3 
was investigated.  Curves were fit to a simple Langmuir 1:1 model. Calculated Kd values 
are shown in Figure 3.2.  As expected, α5β1 binding was found to depend on the 
presence and spatial orientation of the PHSRN site.  Equilibrium dissociation constants 
were calculated for each analyte, and FnIII9*10 was found to have the lowest Kd of all 
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FnIII9'10 variants, with a value of 12.9 nM.  FnIII9p10,  FnIII92G10 , FnIII94G10 were 
found to have Kd values of 3100 nM, 417 nM, and 2530 nM, respectively.  Fn and Ln 
were found to have Kd values of 44 nM and 519 nM, respectively.  Though Ln is not 
typically regarded as a ligand for α5β1, there have been previous reports demonstrating 
interactions between these molecules.  (151)  
Kd values for integrins αvβ3  
 
Evaluation of FnIII9*10 binding to integrin αvβ3 was not dependent on the 
presence or spatial orientation of the PHSRN site, which was expected as αvβ3 
interactions occur through the RGD site alone.  Equilibrium dissociation constants were 
calculated for each analyte, and Kd values were within the same range for all FnIII9*10 
variants (Figure 3.2).  FnIII9*10, FnIII9P10, FnIII92G10, and FnIII94G10 were found to 
have Kd values of 59.6 nM, 25.9 nM, 44.5 nM, and 21.5nM, respectively.  Though all 
values were comparable, minor differences in binding were observed, and, interestingly, 
an opposite trend from α5β1 binding was observed, such that affinity for FnIII9*10 < 
FnIII92G10 < FnIII9P10 < FnIII94G10.  Fn was found to have a Kd value of 9.59 nM, while 
only minimal binding was observed to Ln. 
Epithelial cell spreading on FnIII9-10 variants 
 
To characterize α3β1 binding to FnIII9*10 variants in a cell system and 
subsequent changes in cell spreading, RLE-6TN cells, an alveolar epithelial cell line, 
were cultured on Fn fragments, Fn, and Ln for a period of 3 hours and then stained for 
integrin subunits α3 and actin.  This cell type highly expresses α3β1 and also expresses 
α5β1 and several αv integrins.  Cells cultured on Ln and FnIII9*10 displayed staining for 
α3, while cells cultured on Fn and all other FnIII9-10 variants displayed minimal staining 
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for α3 integrins (Figure 3.3).  Cells cultured on FnIII9*10 displayed a rounded, cuboidal 
morphology and diffuse staining for actin, which was similar to cellular responses on Ln.  
Cells cultured on Fn and all other FnIII9-10 variants displayed were more spread and 
began to display aligned actin filaments.  Cell shape was further characterized through 
analysis of circularity, with values closer to 1 indicating a more rounded cell.  Cells 
cultured on FnIII9*10 exhibited a circularity value of 0.79, which was similar to cells 
cultured on Ln, with a circularity value of 0.73.  Cells cultured on Fn and all other FnIII9-
10 variants were found to have significantly lower circularity values compared to cells 




Data from Ashley Brown 
 
Figure 3.3:  Cell spreading on FnIII9-10 variants.  To evaluate cell-surface integrin 
binding to FnIII9-10 variants and control surfaces and cell spreading responses, RLE-
6TN cells were cultured on FnIII9*10, FnIII9p10, FnIII2G10, FnIII4G10, Fn, or Ln coated 
surfaces for 3 hours.  α3β1 integrin binding was visualized through immunofluorescence 
staining (green), and actin (red) was visualized through staining with Texas-red-X 
conjugated phalloidin.  Circularity was calculated to measure differences in cell 




Epithelial cell attachment to FnIII9-10 variants is integrin dependent  
 
 To characterize how epithelial cells attach to different FnIII9-10 variants, RLE-
6TN cells were incubated with α3, α5, or αv antibodies or combinations of the three for 
30 minutes, then plated on each of the FnIII9-10 fragment, Fn, or Ln and allowed to 
attach for 30 minutes. The attached cells were fixed to the surface, stained, and 
absorbance measured. The results shown are presented as percent of 100% attachment. 
These data coincide closely with the SPR results, indicating that cell attachment to Ln 
and FnIII9*10 surfaces is highly dependent on α3 integrin, while cell attachment to 
FnIII92G10, FnIII94G10, and Fn was predominantly mediated by αv integrin (Figure 3.4).  
Interestingly, cells cultured on the FnIII9p10 surface, appear to mediate attachment 
through both α3 and α5 integrins. Previous studies have suggested that the RGD and 
PHSRN sites serve as an on/off switch for α5β1 binding to Fn such that destabilization of 
the PHSRN and RGD sites may turn the switch off for α3β1/α5β1 binding and on for αv 
integrin binding.  Although this is supported by our results with the 2-glycine and 4-
glycine insertion variants, it appears that a mutation in the synergy site is not sufficient to 
drive epithelial cells to predominantly attach through αv integrin over α3 and α5 integrin.  
 Overall, these results indicate that stabilization of the RGD and synergy sites in 
the FnIII9*10 variant facilitate cell attachment predominantly through α3 and α5 
integrins which is typical of epithelial cell homeostasis and healthy repair, while 
destabilization of the two binding sites through an increased linker region in FnIII92G10 
and FnIII94G10 drives cell attachment predominantly through αv integrins, typically seen 










Figure 3.4: Alveolar epithelial cells attach to FnIII9-10 variants through α3, α5, and 
αv integrins. RLE-6TN cells were incubated with α3, α5, or αv blocking antibodies, and 
cultured on each of the FnIII9-10 variants, Fn, or Ln. Results are pooled from three 





These results show that Fn binds integrin α3β1 in cell-free system, and this 
binding is dependent on the presence of the PHSRN site and is dependent on the spacing 
relative to the RGD site. These findings have implications in dynamic epithelial tissue 
wound healing responses since integrin α3β1 is highly expressed by many epithelial cells, 
which interact with Fn predominantly during wound healing.  In addition, studies suggest 
that the PHSRN site acts to stabilize the high affinity conformation of the RGD site 
required for α5β1 integrin binding.  The results presented here confirm these studies and 
also show that α3β1 integrin binding to Fn is also dependent on the relative positioning of 
the RGD and PHSRN sites.   
Because α3β1 and α5β1 integrin are involved in epithelial wound repair, these 
findings that α3β1 integrin, like α5β1 integrin, binds to Fn in a synergy dependent 
manner have implications in cell interactions during wound healing.  Alveolar epithelial 
type II cells (ATII) only express α5β1 integrin in response to injury; (19) therefore, it is 
likely that integrin α3β1 binds Fn with great affinity in this cell type in early wound 
repair before α5β1 integrin is highly expressed.  Though α5β1 appears to be the main Fn 
receptor during alveolar wound repair, integrin blocking experiments with airway 
epithelial cells showed that in addition to α5, β1, and Fn blocking antibodies, α3 
blocking antibodies also resulted in a significant decrease in wound repair (19).  
Interestingly, it has been shown that integrin α3β1 binding to Fn can be affected by the 
presence of α5β1 integrin such that α3β1 binding is low in cells expressing α3β1 and 
α5β1 at comparable levels, but α3β1 binding to Fn is greatly enhanced in cells that 
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highly express α3β1 compared to other integrins (118). These reports, along with the 
results of these studies, suggest that α3β1 binding to Fn may modulate wound repair by 
facilitating binding to ECM in a wound healing environment as the ECM composition 
transitions from predominantly Ln to high levels of Fn.   
SPR experiments demonstrate similar affinities of all FnIII9-10 variants for 
integrin αvβ3, with all FnIII9-10 variants showing affinities in the 10s of nM range.  
However, small variations were observed, with a trend of increasing affinity opposite of 
those observed with PHSRN-dependent integrins α3β1 and α5β1, such that affinity of 
FnIII9*10 < FnIII92G10 < FnIII9P10 < FnIII94G10.  This indicates that increasing the 
linker region between the 9th and 10th type III repeats or mutations in the PHSRN site 
may make the RGD site more accessible to αvβ3.  The RGD and PHSRN sites have 
previously been described as an on/off “switch” for α5β1 binding to Fn.  These findings 
shown that in the context of epithelial cells, destabilizing the PHSRN and RGD sites may 
turn the switch off for α3β1/α5β1 binding and on for αv integrin binding.  Highlighting 
the significance of such an integrin switch, binding of α3β1/α5β1 integrins have 
markedly different effects on epithelial phenotype compared to αv integrin binding.  
Integrin α3β1 epithelial cell interactions are associated with maintenance of epithelial 
phenotype and wound healing, while interactions with αv integrins have been associated 
with abhorrent wound healing, scar tissue formation, epithelial to mesenchymal 
transitions, and even tumor metastasis (17, 24, 26, 44). Functionally, these interactions 
were validated through cell attachment assays showing that alveolar epithelial cells bind 
to each of the FnIII9-10 variants through different integrin profiles based on the location 
and stabilization of the RGD and synergy sites. Finally, the physiological relevance of 
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these interactions were confirmed by demonstrating differences in cell spreading in 
epithelial cells cultured on FnIII9*10 compared to cells cultured on FnIII9*10 with 
mutation in the PHRSN site or alterations in the spatial orientation of RGD and PHSRN.  
These studies provide insights into how Fn interactions can contribute to normal vs. 
pathological wound healing and provide a model system for use in studying the affects of 
biochemical changes of the ECM in the onset and progression of epithelial cell 
pathogenesis associated with pulmonary fibrosis. 
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CHAPTER 4 
INTEGRIN SPECIFIC RESPONSES TO FIBRONECTIN TYPE III DOMAINS 




The extracellular matrix (ECM) is essential in directing numerous cellular 
processes including spreading, proliferation, and differentiation. Cells adhere and interact 
with their underlying ECM through specific transmembrane receptors known as integrins, 
which are intracellularly linked to the cell cytoskeleton via macromolecular assemblies 
known as focal adhesions.  The physical binding of the ECM to integrins to the 
cytoskeleton represents the primary mechanotransductory axis of the cell and enables 
cells to both apply forces to the ECM and to sense mechanical perturbations emanating 
from the ECM microenvironment.(6, 131, 152) Recent evidence suggests that only 
specific integrins are mechanosensory and therefore cells may be more or less sensitive to 
the mechanics of their environment depending on the ECM ligands presented.(153-155) 
Integrins bind to ECM molecules through specific sequences on the ECM proteins. There 
exist numerous ECM proteins have several binding sites for multiple integrins. 
Additionally, some individual integrin binding sequences can bind multiple integrins, 
resulting in the possibility for multiple cellular responses from the same ECM molecule, 
thus the interplay between integrin selectivity of the ECM and the cell’s responsiveness 
to mechanical stimuli are quite complex.(155, 156) 
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ECM-integrin interactions play a major role in directing cell processes critical to 
tissue development, regeneration, as well as pathology and thus are of great interest in 
biomaterials research. Epithelial to mesenchymal transition (EMT), the differentiation of 
cells from an epithelial to mesenchymal phenotype, is one such cell behavior controlled 
in part by the ECM. (69, 70) EMT is critical in normal embryonic development of 
complex tissues, tissue repair and regeneration, as well as several pathologies like fibrosis 
and cancer metastasis.(30, 69) Understanding ECM-cell interactions that regulate EMT 
and how to control them are critical for tissue engineering applications. In particular, by 
finely controlling ECM-integrin interactions through biomaterials design, directed EMT 
could significantly impact regenerative medicine approaches. 
EMT has been shown to occur in response to numerous different factors, 
including transforming growth factor beta (TGFβ), tumor necrosis factor alpha (TNFα), 
and epidermal growth factor (EGF).(65, 71-73) EMT can also take place in response to 
extracellular matrix proteins including fibronectin (Fn) binding to certain integrins.  
While the exact molecular mechanisms for ECM-mediated EMT are still unclear, data 
from our lab and others has established that engagement of specific integrins, such as 
α3β1, play a strong EMT-inhibitory role whereas others, like αvβ3, may serve to 
promote EMT.(30, 44, 143)  
Integrin binding to ECM ligands on proteins, including fibronectin and laminin, 
occurs through specific binding sequences, such as the well-documented Arg-Gly-Asp 
(RGD) sequence. Many Fn-integrin interactions occur through the RGD sequence, which 
is located on the 10th type III repeat of Fn. In addition to the RGD sequence, few integrins 
are known to engage a second recognition sequence (PHSRN), or the “synergy” site, 
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found on the adjacent 9th type III repeat.(17, 116, 122, 139) Previous reports suggest that 
under small, physiologically relevant forces the 10th type III repeat can partially unfold, 
thus present multiple conformations that result in the graded decoupling of RGD and 
synergy.(13, 16, 17) These different conformations of the 9th and 10th type III repeats can 
greatly influence specific integrin binding.(122, 125) We previously found that 
stabilization of the 9th type III repeat of Fn increases α5β1 integrin affinity resulting in 
enhanced MSC osteodifferentiation, and inhibition of the early EMT program in 
epithelial cells.(44, 144) Therefore, engineering the conformation of the cell adhesive 9th 
and 10th type III repeats of Fn may serve as a way to control EMT for complex tissue 
engineering applications.  
In addition to integrins, the physical properties of the ECM, such as the matrix 
stiffness, contributes to the process of EMT. (Unpublished data, (7, 9, 131, 132, 157, 
158)) Specifically, cells are capable of sensing the underlying matrix stiffness via specific 
integrin-focal adhesion complexes, and will attempt to match their internal stress to the 
external environment.(131, 132) Mechanistically, it has been shown that cells cultured on 
increasingly rigid substrates increase the activation of actinomyosin contractile signaling 
molecules such as Rho GTPase, Rho associated kinase (ROCK), and myosin light chain 
kinase. Increased cell contractility has been established as a primary mechanism for 
TGFβ activation.(12, 37, 46, 65) Specifically, αvβ6 integrin binds RGD sequences on the 
latent TGFβ complex. The application of cell contractile forces on the integrin TGFβ 
complex results in mechanoactivation of the potent growth factor. (31, 32, 36, 159) The 
consequence of this elegant system is cell differentiation on stiff substrates but not soft 
substrates.  In the case of EMT, TGFβ receptor engagement results in the down 
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regulation of epithelial genes such as E-cadherin and cytokeratins and up regulation of 
mesenchymal genes including α-smooth muscle actin (α-SMA).(36, 46, 160)  
Since both biochemical and mechanical stimuli have been shown to affect EMT 
events, we sought to explore how these two factors may synergistically control EMT. We 
hypothesized that epithelial cell activation of TGFβ and subsequent EMT would only be 
supported on stiff substrates presenting adhesive ligands that preferentially bind αv 
integrins.  The hypothesis was tested using a variety of recombinant variants of the 9th 
and 10th type III repeats (FnIII9-10) created in our lab including i) a stabilizing (L1408-P) 
point mutation (FnIII9*10), ii) a dominant negative R-A mutation in the synergy site 
(FnIII9p10), iii) a 2xGly insertion in the linker region between the 9th and 10th type III 
repeats (FnIII92G10), and iv) a 4xGly insertion in the linker region (FnIII94G10). These 
fragments have been shown to display a graded loss of affinity for α3 and α5 integrins 
with increasing decoupling of RGD and synergy and display constant affinity for αv 
integrins.  Understanding the effects of orthogonal biochemical and mechanical cues on 
EMT will allow us to better mimic in-vivo environments and may be a first step to 
engineering biomaterials with exceptionally high levels of control for tissue regeneration 








Materials and Methods 
Production and purification of FnIII9-10 variants 
Cloning of the wild type FnIII9-10 into the pGEX4T bacterial expression vector 
was performed as previously described.  A Leu1408 to Pro mutation (FnIII9*10) was 
made using the parent pGEX4T-FnIII9-10 vector as described previously.  FnIII9*10 
variants displaying i) a dominant negative R-A mutation in the synergy site (FnIII9p10), 
ii) a 2xG insertion in the linker region (FnIII92G10), or iii) a 4xG insertion in the linker 
region (FnIII94G10) were then created using the QuikChange® II-E Site-Directed 
Mutagenesis Kit (Stratagene, La Jolla, CA). All plasmids were introduced to and 
maintained in the electro-competent XL-1 Blue E.coli strain provided and cultured in LB 
+ ampicillin plates at 37°C. Plasmids were extracted from cultures using the QIAquick 
Spin Miniprep Kit (QIAGEN, Valencia, CA) and verified via sequencing (Johns Hopkins 
Synthesis & Sequencing Facility, Baltimore, MD). 
Expression vectors were transformed into BL21 E.coli and individual clones 
picked for subsequent expansion and protein production.  Transformed BL21 were grown 
in LB with ampicillin (100 µg/ml) and protein production was induced by addition of 
IPTG.  Following 3-4 hours of protein production cultures were centrifuged and lysed by 
freeze thaw cycling.  Recombinant GST-FnIII9-10 proteins were purified on a GST-Prep 
column (GE Healthcare) and the GST tag subsequently cleaved with thrombin.  Purity of 





Poly-acrylamide gel production:    
Poly-acrylamide (PA) gels of varying bisacrylamide concentrations were created 
on amino-silanated coverslips as previously described.(161) PA gel solutions were 
produced by combining acrylamide and bisacrylamide to final concentrations of 8% 
acrylamide (Biorad, Hercules, CA, USA) and 0.048%, 0.208%, or 0.391% bis (Biorad) to 
obtain gels with final elastic moduli of 2 kPa, 16 kPa, or 32 kPa respectively. 60 µl of 
each solution was polymerized by the addition of ammonium persulfate (VWR, West 
Chester, PA, USA) and N,N,N’,N’-tetramethylethylenediamine (Biorad, Hercules, CA, 
USA) (1% and 0.1%  final concentration respectively).  The gels were allowed to 
polymerize for approximately 30 minutes, then washed three times with PBS. FnIII9-10 
variants were covalently attached to the surface using the heterobifunctional crosslinker 
sulfosuccinimidyl-6- (4’-azido-2’ nitrophenyl-amino) hexanoate (sulfo-SANPAH; Pierce 
Chemical Co., Rockford, IL., USA).  Following an overnight incubation with the Fn 
fragments, gels were washed three times with PBS.  
Cell Culture: 
RLE-6TN cells, an alveolar epithelial cell line were obtained from ATCC, and 
grown in DMEM/F12 media supplemented with 10% fetal bovine serum and 1% 
penicillin / streptomycin (P/S). To determine the combined affect of different Fn 
fragments and substrate rigidity on epithelial cell fate, cells were plated at a density of 
100,000 cells/cm2 on polyacrylamide gels with Fn fragments cross linked onto the surface 
with the following rigidities: E = 2kPa, 16kPa, 32kPa, or on glass coverslips coated with 
Fn or Ln as controls. For experiments utilizing the different Fn fragments, cells were 
plated on FnIII9-10-immobilized (2 µM) gels placed in 1% bovine serum albumin 
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(BSA)- blocked plates and cultured in DMEM/F12 media supplemented with 10% Fn-
depleted serum for five days. Media was changed every 48 hours.  
Immunofluorescence staining and circularity analysis:  
 Following culture for 5 days, cells were washed with PBS, fixed with 4% 
formaldehyde, permeabilized with 0.2% Triton-X 100 and then blocked with 10% goat 
serum.  Primary mouse anti-α-SMA (1A4, Sigma-Aldrich) or mouse anti-E-cadherin 
(36/E-cadherin, BD Transduction Laboratories) antibodies were incubated overnight then 
washed thoroughly with PBS + 1.5% goat serum.  Alexa-Fluor-488-conjugated goat-anti-
mouse (Invitrogen) was used as the secondary antibody for both markers in separate 
staining experiments. To characterize cell shape, actin was stained with Texas-red 
phalloidin (Invitrogen) and nuclei were stained with Hoechst (Invitrogen). Images were 
acquired with a Nikon Eclipse (TiE) inverted fluorescence microscope at 20X 
magnification (PlanFluor 20X, 0.5 NA objective) with a CoolSNAP HQ2 
Monochromatic CCD camera.  Experiments were performed in triplicate, and images 
presented are representative from 5-10 random fields for each independent experiment.  
To characterize circularity, area and perimeter of individual cells stained for actin were 
determined for each condition using Image J (NIH Freeware) image processing software, 
then circularity was determined using the equation circularity = 4π(area/perimeter2).   
Three independent images were analyzed for each condition, and at least 10 cells were 
analyzed per image.  Data is pooled from all 3 images analyzed per condition.  
Immunoblot:  
 RLE-6TN cells were cultured for 5 days as described above then washed with PBS 
and cells lysed directly in Laemmli buffer containing protease inhibitors (Roche Applied 
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Sciences).  Total protein concentration was determined using the BCA protein 
quantification kit (Pierce Chemical Co.).  Forty µg of total protein was separated by 
electrophoresis on a 4-15% gel, then transferred to a nitrocellulose membrane using a 
semi-dry transfer system, blocked with 5% nonfat dry milk in TBS, then incubated with 
E-cadherin (36/E-cadherin), α-SMA (1A4), or GAPDH (14C10, Cell Signaling 
Technologies, Boston, MA, USA) antibodies overnight at 4° C.  Following washing with 
TBS + 0.1% Tween 20, membranes were incubated for 2 hours with IR secondary 
antibody (Licor), washed, and then imaged using the Odyssey IR scanner.  Western blots 
were quantified using Image J image processing software, using GAPDH as the 
endogenous control. 
TGFβ activation assay:   
 RLE-6TN cells were cultured on Fn fragment-PA gels, Fn-coated glass, or 
Ln-coated glass in Fn depleted growth media as described above. TGFβ activation was 
determined by a mink lung epithelial cell (MLEC) assay as previously described (162). 
MLECs stably transfected with an expression construct containing a truncated Pai-1 
promoter fused to the firefly luciferase reporter gene respond in a dose dependent manner 
to active TGFβ, but are incapable of activating TGFβ.  After 5 days of RLE-6TN culture 
on the various substrates, MLECs were added at a density of 50,000 cells/cm2 on top of 
the RLE-6TN cells in serum free DMEM/F12 media + 1% BSA.  Cells were co-cultured 
for 16 hours, lysed and luciferase activity was determined via the One-Glo luciferase 
assay (Promega).  Luminescence was measured with a Synergy H4 Multi-Mode Plate 
Reader (BioTek, Winooski, VT, USA).  TGFβ activation is presented as pg/mL 
calculated from normalized luminescence compared to MLEC only (unstimulated) wells.  
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Results presented are pooled from 3 independent triplicate experiments.   
Statistical Analysis:  
All statistical analysis for 3 or more experimental groups was performed by two-
way ANOVA using Prism (GraphPad Software Inc., La Jolla, CA, USA). Statistical 
significance between groups was determined by performing Tukey’s post hoc analysis. 
All data is presented as mean +/- SEM and statistical significance is achieved for p<0.05.   
 
Results 
Alveolar epithelial cells maintain an epithelial phenotype when engaging the stabilized 
FnIII9*10 fragment. 
Utilizing PA gels and surface immobilized Fn mutants and varying stiffness from 
2 to 32 kPa, alveolar epithelial cells were cultured for 5 days and then analyzed for 
different EMT responses. EMT was characterized through analysis of cell 
circularity/spreading, and expression of different epithelial and mesenchymal markers by 
immunofluorescence staining and western blots. Alveolar epithelial cells have been 
shown to undergo EMT on Fn-coated glass coverslips but maintain an epithelial 
phenotype on Ln-coated glass coverslips. Therefore, these conditions were used as 
controls and, as expected, EMT was observed on Fn-coated glass as indicated by high 
expression of α-SMA and low levels on E-cadherin at cell-cell contacts. Contrary, cells 
cultured on Ln-coated glass exhibited an epithelial phenotype as indicated by low levels 
of α-SMA and maintenance of E-cadherin expression at cell-cell contacts. 
Cells cultured on 2kPa and 16kPa gels with the FnIII9*10 fragments maintained 
an epithelial phenotype with positive staining for E-cadherin at cell-cell contacts and 
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minimal staining for α-SMA as well as high cell circularity. At 32kPa, staining for E-
cadherin decreased and staining for α-SMA slightly increased showing a slight shift to a 
more mesenchymal phenotype.  In contrast, cells cultured on gels presenting the 
FnIII9p10, FnIII92G10, or FnIII94G10 mutants all showed an up-regulation of 
mesenchymal markers, a loss of cell-cell contacts, and decreased cell circularity at all 
substrate stiffness values (Figure 4.1). In addition, EMT was monitored by analyzing cell 
spreading and cytoskeletal organization / stress fiber formation. Alveolar epithelial cells 
were once again cultured on combinations of different Fn fragment mutants and 
substrates of varying stiffness for 5 days. They were then stained with Texas Red-X 
conjugated phalloidin to visualize the actin cytoskeleton. Cells cultured on the stabilized 
FnIII9*10 mutant displayed the typical rounded epithelial morphology and diffuse 
cortical staining for actin. In contrast, cells cultured on all other mutants displayed an 
elongated morphology and thick, aligned actin filaments indicative of stress fibers. 
Despite previous reports indicating the inability of cells on soft substrates to generate 
stress fibers, we observed that epithelial cells cultured on FnIII9p10, FnIII92G10, 
FnIII94G10 all showed of the formation of a few stress fibers even on low stiffness (2kPa) 
gels. Cell circularity was calculated to quantify differences in observed cell shape.  




Figure 4.1: Analysis of epithelial and mesenchymal markers of RLE-6TN cells 
cultured on differing Fn fragment-substrate stiffness combinations.  RLE-6TN cells 
were cultured on differing fragment-stiffness combinations for 5 days then analyzed for 
epithelial and mesenchymal protein expression through immunofluorescence staining for 
E-cadherin (a-f, s-x, kk-ll) and α-SMA (g-l, y-dd, mm-nn). The actin cytoskeleton was 
visualized by staining with Texas-red phalloidin and the nuclei stained with Hoechst (m-
r, ee-jj, oo-pp). Fluorescent images were acquired with a Nikon Eclipse (TiE) inverted 
fluorescence microscope at 20X magnification. Experiments were performed in triplicate, 




The shift from an epithelial to mesenchymal phenotype was further quantified by 
western blots for E-cadherin (epithelial) and α-SMA (mesenchymal). Western blots were 
quantified and expressed as fold change compared to expression on 2kPa gels, 
normalizing for protein loading differences with the GAPDH signal. Higher expression of 
E-cadherin was seen on the 2kPa gels for each of the fragments compared to higher 
substrate stiffnesses, while expression of α-SMA was higher on the stiffer substrates. 
Although some E-cadherin expression was observed on higher substrate stiffnesses and 
on the destabilized mutants, it was lost from cell-cell contacts. This corroborates 
observations that E-cadherin is lost from cell-cell contacts early in the progression of 
EMT but is still observed intracellularly.  The loss of E-cadherin protein levels occurs 
well into the EMT program.  This fact accentuates the relevance of the magnitude of E-
cadherin loss on the destabilized Fn mutants. Differences in protein expression, in 
general, correspond with the immunohistochemistry results, indicating that stabilization 
of the RGD and PHSRN synergy by the FnIII9*10 mutation supports an epithelial 
phenotype (inhibits EMT) at higher stiffnesses concomitant with its ability to bind α3 and 
α5 integrins.  On the contrary, the decoupled (FnIII9p10) and destabilized (FnIII92G10, 
FnIII94G10) mutants, which decreasingly bind α3 and α5 integrin, still support EMT, 








Figure 4.2: Analysis of circularity of cells cultured on various fragment-stiffness 
combinations. Cells were cultured for 5 days, lysed and responses were analyzed 
through changes in actin cytoskeleton alignment and cell circularity. Experiments were 
performed in triplicate and significance is reported compared to either Fn or Ln at either 






Figure 4.3: Analysis of epithelial and mesenchymal protein expression of cells 
cultured on various fragment-stiffness combinations. Cells were cultured for 5 days, 
lysed and EMT responses were analyzed through changes in epithelial and mesenchymal 
protein expression western blotting for E-cadherin (epithelial) (A) and α-SMA 
(mesenchymal) (B), and GAPDH (endogenous control). Western blots were quantified 
and expressed as fold changed compared to expression on the 2kPa gels using GAPDH as 
the endogenous control (A, B).  
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EMT events are dependent on cell contractility 
Based on previous observations that epithelial cell stiffness increases with 
increasing matrix rigidity, we investigated if the observed EMT on the Fn fragment-
stiffness combinations maintained this dependency. Alveolar epithelial cells were again 
cultured for 5 days on differing Fn fragment mutant-substrate stiffness combinations in 
the presence or absence of the ROCK inhibitor, Y-27632, and EMT events characterized 
as previously described. In the presence of the ROCK inhibitor, cells on all substrates 
displayed positive staining for E-cadherin at cell-cell contacts and minimal staining for α-
SMA (Figure 4.4). In addition, cells on all substrate combinations maintained a round, 
epithelial morphology as indicated by quantitative circularity analysis (Figure 4.5). 
Finally, protein expression for E-cadherin and α-SMA remained unchanged in cells 
culture on each fragment and stiffness combination (Figure 4.6). These results strongly 
indicate that blocking epithelial cell contractility is able to overcome matrix/substrate 
effects and implicates activation of the cell contractile machinery as a primary target 














Figure 4.4: EMT events are dependent on cell contractility.  RLE-6TN cells were 
cultured on fragment-stiffness combinations in the presence or absence of 10 µM Y-
27632 ROCK inhibitor for 5 days and then EMT responses were analyzed through 
changes in epithelial and mesenchymal protein expression through immunofluorescence 
staining for E-cadherin (a-f, s-x, kk-ll) and α-SMA (g-l, y-dd, mm-nn). The actin 
cytoskeleton was visualized by staining with Texas-red phalloidin and the nuclei stained 




 Figure 4.5: Fn fragment -- substrate stiffness circularity is dependent on cell 
contractility. RLE-6TN cells were cultured on fragment -- stiffness combinations in the 
presence or absence of 10 µM Y-27632 ROCK inhibitor for 5 days and then responses 
were analyzed through changes in actin cytoskeleton alignment and cell circularity. 
Experiments were performed in triplicate, and data was collected from 5-10 random 





Figure 4.6: Fn fragment-substrate stiffness EMT is dependent on cell contractility. 
RLE-6TN cells were cultured on fragment - stiffness combinations in the presence or 
absence of 10 µM Y-27632 ROCK inhibitor for 5 days and EMT responses were 
analyzed through changes in epithelial and mesenchymal protein expression by western 
blot for E-cadherin (epithelial) (A) and α-SMA (mesenchymal) (B), and GAPDH 
(endogenous control). Western blots were quantified and expressed as fold change 




Alveolar epithelial cells display enhanced TGFβ activation in conjunction with cell 
contractility and EMT 
Previous studies have shown that elevated levels of cell contractile forces enable 
the activation of TGFβ, a potent EMT inducer, from its matrix associated latent form. 
Since inhibition of contractile forces eliminated the substrate-dependent EMT responses, 
we investigated if differences in TGFβ activation on Fn fragment -- substrate stiffness 
combinations could explain, in part, the observed substrate-mediated EMT events. To 
determine if differences in fragment-stiffness combinations induced changes in TGFβ 
activation, the mink lung epithelial reporter cell (MLEC) bioluminescence co-culture 
assay was performed (Figure 4.7). Generally, alveolar epithelial cells were found to 
increasingly activate TGFβ in response to increased substrate compliance.  Furthermore, 
epithelial cells cultured on the destabilized Fn mutants activated significantly greater 
amounts of TGFβ compared to the stabilized mutant (FnIII9*10) or Ln.  Statistical 
comparisons were made across all sample groups.  The following samples were 
statistically different from the Ln control: FnII9p10 (32kPa), FnIII92G10 (2, 16, 32kPa), 
and FnIII94G10 (2, 16, 32kPa).  The following samples were statistically different from 
the Fn control: Fn9*10 (2, 16, 32kPa) and FnIII9p10 (2kPa).  The FnIII9p10 (16kPa) 
sample was not statistically different from either control.  As predicted, the control 
groups cultured on Fn-coated glass showed high levels of TGFβ activation, while those 
cultured on Ln-coated glass showed significantly less (p <0.01) levels than Fn that were 







Figure 4.7: TGF-β activation is necessary for EMT. RLE-6TN cells were cultured for 
5 days on differing fragment -- stiffness combinations and then levels of TGFβ activation 
was determined using the MLEC bioluminescence co-culture assay. TGFβ activation is 
reported as pg/mL, and results shown are pooled from 3 independent triplicate 
experiments. Significance is reported compared to either Fn or Ln at either p <.05 (*) or p 













































































Cell-integrin interactions play a major role in directing cellular processes that 
drive tissue regeneration. Understanding these interactions and how to control them at the 
biomaterial-cell interface is critical for tissue engineering applications that aim to direct 
cell fate in vitro, or direct tissue regeneration in vivo after injury. Although much effort 
has been made to prevent biomaterial-associated pathologically related cell behaviors, 
like EMT, these transitions are necessary for proper repair and regeneration of most 
complex tissues. As such, there is a growing need for new biology that informs 
biomaterials design.  Cell-integrin interactions are central to directing EMT events, and if 
uncontrolled lead to pathological conditions. However, if finely controlled, directed EMT 
could have significant potential for regenerative medicine applications, such as directing 
complex tissue formation from a single cell population, like stem or progenitor cells. 
Here we show for the first time that EMT-related responses can be controlled, in part, 
through cell adhesive Fn fragments which have been engineered to differentially engage 
specific integrins. These fragments, or similarly designed integrin-specific ECM adhesive 
polypeptides, may in the future be used in three-dimensional synthetic biomaterials to 
direct complex epithelial cell responses, e.g. EMT and branching morphogenesis, 
facilitating tissue regeneration.  
The work presented here is based on previous data illustrating that α3β1 and 
α5β1 integrin engagement has markedly different effects on epithelial phenotype 
compared to αv integrin engagement. Specifically, α3 integrins are associated with 
maintenance of an epithelial phenotype while αv interactions are associated with EMT.  
In addition, the RGD and PHSRN sites of Fn’s cell binding domain have been described 
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as a possible integrin ‘mechanoswitch’ for α5β1 binding to Fn.(30, 44, 142, 143) 
Unpublished data from our lab strongly suggests that α3β1 integrin shares this binding 
behavior to Fn’s cell binding domain.  Therefore, destabilization of this critical region, as 
achieved through our FnIII9p10, FnIII92G10, and FnIII94G10 mutants, should turn the 
switch ‘off’ to α3 and α5 integrin thus pushing the Fn fragments toward binding 
predominately αv integrins, and ultimately driving EMT. Our results strongly support 
this hypothesis.  In particular, the Fn fragment variants that display higher αv to α3/α5 
binding affinities enable epithelial cells to undergo EMT even on extremely soft 
substrates that are inherently inhibitory to the process.  Likewise, structural stabilization 
of FnIII9-10 is capable of supporting epithelial phenotypes even on substrate stiffness 
values that we have previous shown as promoting EMT (>8kPa).  Taken together, our 
results indicate that both the biochemical and mechanical signals from the 
microenvironment play a role in activation of the EMT program.  Perhaps not 
unexpected, the data suggest that neither the conformation of Fn nor the substrate 
compliance is a dominant effector.  In other words, it appears that either the ligand or the 
compliance is capable of overcoming the effect of the other.  The response of epithelial 
cells to the array of conditions tested also suggests that cells have an integrated response 
to combinations of integrin engagement and compliance matching (the notable exception 
being Ln).   Of particular interest is the finding that while FnIII9*10 prevented significant 
cell spreading and TGFβ activation, the epithelial cells still display some indications of 
EMT on the stiffest substrate (32kPa).  On the opposite end of the spectrum, we found 
our original hypothesis to be only partially correct.  Specifically, epithelial cells engaging 
Fn fragments that predominately support αv integrin engagement actively initiated the 
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EMT program despite being cultured on substrates with stiffness values that do not 
support cell contraction.  Future studies elucidating the molecular details of these varied 
responses will no doubt provide interesting insights into the complexity of EMT. 
In conclusion, we demonstrate for the first time, that different combinations of 
substrate compliance and integrin-specific engagement can be used to guide different 




Figure 4.8. Combined substrate compliance and integrin specific engagement drive 
differential epithelial cell phenotypes. Epithelial cells cultured on rigid substrates 
normally facilitate pro-contractile signals. However engagement of α3 integrins by 
utilizing the FnIII9*10 variant can modulate this response and maintain an epithelial 
phenotype (A). Alternatively, epithelial cells on soft substrates normally inhibit pro-
contractile signals, but with engagement of αv integrin by utilizing the FnIII4G10 variant 
cells become contractile and acquire a mesenchymal phenotype (B). 
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These responses appear to be partially regulated through the cell’s ability to activate 
TGFβ, likely via integrin-mediated mechanoactivation.  This work further illustrates that 
altered biophysical states of Fn’s cell binding domain that alter the integrin binding 
profile to this domain are capable of regulating the maintenance of epithelial phenotypes 
or driving EMT and show translational promise in biomaterials-based regenerative 





EXPOSURE TO ENVIRONMENTAL PARTICULATE MATTER 




Over the past decade, several studies have linked deteriorating pulmonary 
conditions to exposure to air pollution and particulate matter (PM). Epidemiological 
studies have linked exposure to particles with diameters less than 10 um with increased 
pulmonary morbidity and mortality. It is estimated that the annual number of premature 
deaths due to particle exposure is approximately one million worldwide(57-59, 61). 
Several different pulmonary effects have been associated with PM exposure, including 
decreased lung development and function, exacerbation of asthma, chronic obstructive 
pulmonary disease (COPD), and pulmonary fibrosis (52, 54, 56). Despite numerous 
epidemiological studies that associate PM with adverse pulmonary conditions, the 
underlying biological mechanisms are not fully understood.  
Ambient PM is a complex mixture consisting of solid particles and liquid droplets 
of varying size and composition. The size of the particles is defined by its aerodynamic 
diameter, which can range from a few nanometers to tens of micrometers, and is highly 
dependent of characteristics such as shape, density, and structure (53, 55, 163). When 
studying biological health effects of PM, particles with aerodynamic diameters of less 
than 10 microns are broken into three subcategories: coarse particles (aerodynamic 
diameters of 2.5um – 10um), fine particles (aerodynamic diameters of 0.1um – 2.5um) 
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and ultrafine particles (<0.1 um), and these are generally referred to as PM10, PM2.5, 
and PM0.1.  
The adverse effects of inhaled PM are highly dependent on the deposition and 
retention of particles within the lung, and this deposition is dependent on the 
aerodynamic properties. In general, large particles primarily deposit in the large airways 
of the respiratory tract, while smaller particles pass directly through the upper airways 
and are able to deposit in the bronchiolar and alveolar regions (54, 56-58, 61). Ciliated 
cells clear most particles deposited in the upper airways in less than 24 hours from 
deposition. However, smaller particles that reach the alveoli cannot be cleared in this 
manner. Particle clearance in the distal lung is attempted by phagocytosis by alveolar 
macrophages, although this process is less efficient for ultra-fine particles. Smaller 
particles that cannot be cleared go on to interact directly with alveolar epithelial cells (54, 
56, 58).  
These smaller particles have been suggested to be more detrimental to progression 
of lung pathologies due to their high surface to mass ratio. Although size is a critical 
factor in reaching the distal lung, previous studies have shown that several components of 
PM are able to activate an inflammatory response and that there are secondary effects that 
can induce cellular damage, which stimulate fibrotic remodeling pathways (95, 98-100).  
A variety of characteristics that contribute to inflammation in the lung have been 
identified both in-vivo and in-vitro, including the content of endotoxins, transition metals, 
and hydrocarbons. Therefore, both the surface area and the surface reactivity of particles 
are potential mediators in the onset and progression of pulmonary pathogenesis (54, 56, 
58).  
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Of particular interest, is that alveolar macrophages, which are recruited in 
response to PM deposition in the lung, store large quantities of latent TGF β that can be 
released upon stimulation. In response to tissue damage, the latent TGF β is released into 
the site of injury, and can be inserted into the matrix of the provisional wound. 
Furthermore, it has been suggested that PM exposure may exert oxidative stress on 
alveolar cells by presenting or stimulating the cells to produce reactive oxygen species 
(48, 49, 60, 102). These reactive oxygen species in turn have the ability to activate stores 
of latent TGF β by direct oxidation of methionine-253 within the LAP peptide. The redox 
reactions cause a rapid conformational change in the LAP, which allows for the rapid 
release of the TGF β homodimer (24, 48, 49, 60, 101, 102). 
As shown in Aim 1 of this work, TGF β is a potent inducer of EMT, which has 
been highly linked with the onset, and progression of pulmonary fibrosis. Furthermore, in 
Aim 1 we show that both the dynamic biochemical and biophysical properties of the 
ECM work together to control TGF β activation, and that this activation initiates the 
progression of EMT. Therefore, we sought to explore if exposure of physiologically 
relevant concentrations of PM2.5, to alveolar epithelial cells alters the activation of TGF 
β and ATII cell phenotype normally seen in response to varied matrix stiffnesses. This is 
of great significance because the lung is exposed to particulate matter on a daily basis. 
Therefore, it is important to explore how processes driving pulmonary fibrosis are 
affected in this highly physiologically relevant condition. Furthermore, exploration of the 
combination of PM and matrix stiffness will give insight into how these processes are 
altered in a pre-fibrotic or fibrotic environment compared to a healthy environment. The 
hypothesis for this work was that exposure of alveolar epithelial cells to PM2.5 would 
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exacerbate the induction of stiffness mediated EMT. The consequence of this combined 
effect would lead to the rationale that exposure to fine particulate matter can further drive 
a fibrotic state leading to increased progression of lung disease. Furthermore, it was 
hypothesized that the intensified EMT response with exposure to PM2.5 could be 
mediated by inhibition of ROS and / or engagement of an epithelial-maintaining Fn 
conformation.  
Materials and Methods 
 
Poly-acrylamide gel production:  
Poly-acrylamide (PA) gels of varying bisacrylamide concentrations were created 
on amino-silanated coverslips as previously described.(161) PA gel solutions were 
produced by combining acrylamide and bisacrylamide to final concentrations of 8% 
acrylamide (Biorad, Hercules, CA, USA) and 0.048%, 0.117%, 0.208%, or 0.260% bis 
(Biorad) to obtain gels with final elastic moduli of 2 kPa, 8kPa, 16 kPa, or 24 kPa, 
respectively. 50 µl of each solution was polymerized by the addition of ammonium 
persulfate (VWR, West Chester, PA, USA) and N,N,N’,N’-tetramethylethylenediamine 
(Biorad, Hercules, CA, USA) (1% and 0.1%  final concentration respectively).  The gels 
were allowed to polymerize for approximately 30 minutes, then washed three times with 
PBS. Fibronectin was covalently attached to the surface using the heterobifunctional 
crosslinker sulfosuccinimidyl-6- (4’-azido-2’ nitrophenyl-amino) hexanoate (sulfo-
SANPAH; Pierce Chemical Co., Rockford, IL., USA).  Following an overnight 
incubation with the fibronectin or fibronectin variants, gels were washed three times with 
PBS. 
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Production and purification of FnIII9-10 variants 
Cloning of the wild type FnIII9-10 into the pGEX4T bacterial expression vector 
was performed as previously described.  A Leu1408 to Pro mutation (FnIII9*10) was 
made using the parent pGEX4T-FnIII9-10 vector as described previously.  FnIII9*10 
variants displaying i) a dominant negative R-A mutation in the synergy site (FnIII9p10), 
ii) a 2xG insertion in the linker region (FnIII92G10), or iii) a 4xG insertion in the linker 
region (FnIII94G10) were then created using the QuikChange® II-E Site-Directed 
Mutagenesis Kit (Stratagene, La Jolla, CA). All plasmids were introduced to and 
maintained in the electro-competent XL-1 Blue E.coli strain provided and cultured in LB 
+ ampicillin plates at 37°C. Plasmids were extracted from cultures using the QIAquick 
Spin Miniprep Kit (QIAGEN, Valencia, CA) and verified via sequencing (Johns Hopkins 
Synthesis & Sequencing Facility, Baltimore, MD). 
Expression vectors were transformed into BL21 E.coli and individual clones 
picked for subsequent expansion and protein production.  Transformed BL21 were grown 
in LB with ampicillin (100 µg/ml) and protein production was induced by addition of 
IPTG.  Following 3-4 hours of protein production cultures were centrifuged and lysed by 
freeze thaw cycling.  Recombinant GST-FnIII9-10 proteins were purified on a GST-Prep 
column (GE Healthcare) and the GST tag subsequently cleaved with thrombin.  Purity of 
the FnIII9-10 variants was established by SDS-PAGE analysis as previous reported.(44, 
144)  
Cell Isolation and Maintenance: 
RLE-6TN cells were purchased from ATCC and maintained in DMEM/F12 
media with 10% FBS and 1% penicillin/streptomycin at 37°C and 5% CO2. Media was 
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refreshed every 2 to 3 days and cells were split upon reaching 95% confluency. 
LIVE/DEAD Assay of cell viability 
RLE-6TN cells were cultured for 24 hours with increasing concentrations of 
PM2.5 ranging from .01ug/cm2 to 50ug/cm2 and cell viability was determined by staining 
with trypan blue. Cells were trypsinized and then resuspended in a 1:1 suspension using 
0.4% trypan blue. The cell suspension was analyzed by counting dead cells (stained blue) 
vs. total cells using a hemacytometer. Each concentration of PM2.5 was tested in 
triplicate and results are presented as % viable cells for each PM concentration.  
Fine Particulate Matter Isolation and Cell Culture Experiments 
Fine particulate matter samples were collected on Teflon filters from the Atlanta 
area (Dekalb county) as part of a study for the Georgia Tech Civil and Environmental 
Engineering department. The samples were collected daily using multichannel particle 
composition monitors (PCM). The specific area of collected PM is located near two 
major highways (I20 and I285), and near a school, both of which can lead to increased 
levels of mobile source generated particulate matter  [8]. In each channel of the PCM, air 
first passes through a cyclone separator to remove particles that are greater than 10um. In 
one channel, the air next passes through a WINS impactor to remove particles that are 
greater than 2.5um. Finally, the remaining particles (i.e. the PM2.5 fraction) is collected 
on a Teflon filter. In channel two, after passing though the cyclone, the air passes through 
an annular denuder to remove acidic and alkaline gases. Then the air passes through the 
WINS impactor and the remaining particles are captured on a nylon filter in order to 
analyze the ionic species. In the third channel, the air passes through a denuder in order to 
remove organic gases, flowed by the WINS impactor, and the particles are collected in a 
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quartz filter for organic and elemental carbon analysis [8, 9]. After collection in the 
particle composition monitors, the filters are stored at  -20°C for later chemical analysis. 
The Teflon filter is stored for exploratory analyses, such as this study.  
In order to prepare the PM2.5 fraction for cell culture experiments, five different 
PM containing Teflon filters were weighed to determine the total particulate mass on 
each filter. Five samples were pooled together to minimize variation based on the day 
collected, and placed in sterile 50 ml centrifuge tubes fully covered with 5ml of diH20, 
and sonicated 5 times for 10 minutes to release the particles captured on the filters. The 
samples were filtered through a 5um diameter pore size filter to remove any larger 
particle debris. The pooled sample was resuspended in DMEM/F12 culture media to a 
final concentration of 100ug/ ml. Serial dilutions were then performed to prepare 
experimental groups of 1:100, 1:1000, and 1:10000 which correspond to physiologically 
relevant concentrations of approximately 10ug/cm2, 1ug/cm2, and 0.1ug/cm2 
respectively. RLE-6TN cells were maintained and passaged in DMEM/F12 media 
supplemented with 10% FBS + 1%P/S. The particulate containing media was made fresh 
for each experiment, keeping total PM mass from the pooled filters consistent for each 
preparation. The fresh particulate containing media was then added directly to cell culture 
wells of varying substrate stiffnesses for subsequent different studies.  
TGFβ activation assay:   
RLE-6TN cells were cultured on Fn or Fn variant coated PA gels, Fn-coated 
glass, or Ln-coated glass with addition of particulate matter as described above. TGFβ 
activation was determined by a mink lung epithelial cell (MLEC) assay as previously 
described. MLECs stably transfected with an expression construct containing a truncated 
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Pai-1 promoter fused to the firefly luciferase reporter gene respond in a dose dependent 
manner to active TGFβ, but are incapable of activating TGFβ.  After 5 days of RLE-6TN 
culture on the various substrates, MLECs were added at a density of 50,000 cells/cm2 on 
top of the RLE-6TN cells in serum free DMEM/F12 media + 1% BSA.  Cells were co-
cultured for 16 hours, lysed and luciferase activity was determined via the One-Glo 
luciferase assay (Promega).  To determine total levels of TGFβ, samples were heated to 
85°C for 10 minutes prior to plating of MLEC cells. To ensure PM alone did not activate 
TGF β, soluble TGF β was added along with PM as a control. Luminescence was 
measured with a Synergy H4 Multi-Mode Plate Reader (BioTek, Winooski, VT, 
USA).  Luminescence values were normalized to MLECs cultured in the absence of 
TGFβ. Levels of active or total TGFβ activation were then calculated through 
interpolation using a standard curve. Results presented are from 3 independent triplicate 
experiments.  
DCFH2-DA Oxidation Assay for measuring ROS 
 Following culture for 5 days, cells were washed with HBSS, and incubated with 
10uM DCFH2-DA for 30 minutes at 37C to measure oxidation. Controls wells were 
included that were not incubated with any dye. After incubation, cells were washed in 
sterile HBSS and CM-DCFH2 fluorescence was measured (excitation of 485/20nm filter 
and emission of 528/20nm filter). Cells were then washed again and incubated with 
5ug/ml Hoescht 33342 for 30 minutes at 37C. The Hoescht fluorescence was measured 
(excitation of 350nm and an emission of 461nm).  The CM-DCFH2 fluorescence was 
normalized to the Hoescht reading to account for cell number.  
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Immunofluorescence staining for EMT markers and cell shape analysis:  
Following culture for 5 days, cells were washed with PBS, fixed with 4% 
formaldehyde, permeabilized with 0.2% Triton-X 100 and then blocked with 10% goat 
serum.  Primary anti-a-SMA (1A4, Sigma-Aldrich) or anti-E-cadherin (36/E-cadherin, 
BD Transduction Laboratories) antibodies were incubated overnight then washed 
thoroughly with PBS + 1.5% goat serum.  Alexa-Fluor-488-conjugated goat-anti-mouse 
(Invitrogen) was used as the secondary antibody. To characterize cell shape, actin was 
stained with Texas-red phalloidin (Invitrogen) and nuclei were stained with Hoescht stain 
(Invitrogen). Images were acquired with a Nikon Eclipse (TiE) inverted fluorescence 
microscope at 20X magnification (PlanFluor 20X, 0.5 NA objective) with a CoolSNAP 
HQ2 Monochromatic CCD camera.  Experiments were performed in triplicate, and 
images presented are representative from 5-10 random fields for each independent 
experiment.  To characterize circularity, area and perimeter of individual cells stained for 
actin were determined for each condition using Image J (NIH Freeware) image 
processing software, then circularity was determined using the equation circularity = 
4π(area/perimeter2).   Three independent images were analyzed for each condition, and at 
least 10 cells were analyzed per image.  Data is pooled from all 3 images analyzed per 
condition. 
Immunoblot for EMT marker protein levels:  
RLE-6TN cells were cultured for 5 days as described above then washed with 
PBS and cells lysed directly in Laemmli buffer containing protease inhibitors (Roche 
Applied Sciences).  Total protein concentration was determined using the BCA protein 
quantification kit (Pierce Chemical Co.).  Forty mg of total protein was separated by 
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electrophoresis on a 4-15% gel, then transferred to a nitrocellulose membrane using a 
semi-dry transfer system, blocked with 5% nonfat dry milk in TBS, then incubated with 
E-cadherin (36/E-cadherin), pan cytokeratin (5D3 + LP34, abcam, Cambridge, MA, 
USA), α-SMA (1A4), prolyl-4-hydroxylase (P4H; 1D3, Santa Cruz Biotechnology, Santa 
Cruz, CA, USA), or GAPDH (14C10, Cell Signaling Technologies, Boston, MA, USA) 
antibodies overnight at 4° C.  Following washing with TBS + 0.1% Tween 20, 
membranes were incubated for 2 hours with IR secondary antibody (Licor), washed, and 
then imaged using the Odyssey IR scanner.  Western blots were quantified using Image J 
image processing software, using GAPDH as the endogenous control. 
AFM nanoindentation analysis:  
RLE-6TN cells with or without the addition of each of the three concentrations of 
PM2.5 were cultured on 8kPa gels in a 0.17 mm thick glass-bottom petri dish (World 
Precision Instruments, Inc.). Using the Asylum MFP-3D-BIO AFM, single force points 
were measured from at least 5 peri-nuclear regions that were greater than 300 nm in 
height by force spectroscopy using contact mode at a scan rate of 1.2 Hz. The silicon 
nitride AFM tip (Veeco) was customized with a 4.74 µm diameter polystyrene bead to 
allow for imaging at appropriate resolution scales and for elastic modulus determination 
using the Hertz-contact model. Single cantilever’s unique spring constants were 
determined using the thermal resonance frequency method, with values typically ranging 
0.1 – 0.3 N/m. To determine the Young’s modulus of each contact point, the Hertz-
contact model for determining the elastic forces between two spheres was used (Eq. 1). 
Using known values from the AFM measurement (xs is scanner displacement; xc is the 
cantilever displacement; c.p. is the contact point) and predetermined values for the 
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cantilever spring constant (k) and beaded-tip radius, the elastic modulus can be solved for 
(E) (bead force, FB, is equal to k* xc). The assumption of an isotropic material or that 
Poisson’s ration (ν) is equal to 0.5 is valid for the small indentation depths under 
operation.                                   
                     Eq. 1 
Statistical Analysis:  
All statistical analysis for 3 or more experimental groups was performed by two-
way ANOVA using Prism (GraphPad Software Inc., La Jolla, CA, USA). Statistical 
significance between groups was determined by performing Tukey’s post hoc analysis. 
All data is presented as mean +/- SEM and statistical significance is achieved for p<0.05.   
 
Results 
Particle Composition Monitor Set up 
Particulate matter to be used in future analyses was collected from 1-March-2004 
to 30-June-2004 using a filter based particle composition monitor (PCM) as part of the 
longer term ASACA program (164). The PCM is a 3 - channel system that collects 24 
hour integrated samples for analysis of ionic, carbonaceous, and metallic species in the 
PM2.5 size range. The monitor is controlled by a data acquisition system (DAS) that 
activates sampling, sequences the filters and controls sample flow to a flow rate of 16.7 
L/min through each channel. Filters were installed approximately one day prior to 
sampling and removed one day following exposure to ambient air. Ambient air was 
drawn through each channel of the monitor and then flowed through denuders for 
selective removal of gases, a WINS impactor for providing a 2.5um size cut, and finally 
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the sampling media. The PCM was mounted approximately 2.5 meters above ground 
(164).  
In channel 1, the sampled air was passed through onto a single Teflon filter.  
PM2.5 captured on the Teflon filter is archived for exploratory analyses, such as this. 
Ionic species including sulfate, nitrate, and ammonium were collected on a nylon filter 
using channel 2. Finally, channel 3 was used for quantification of elemental and organic 
carbon. Regular maintenance of the PCM was performed over the collection period.   
Particulate Matter Sample Analysis 
The average PM over the period during which the filters were used in this analysis 
was 14.2 µg/m 3. Concentrations of water-soluble sulfate, nitrate and ammonium, as well 
as elemental and organic carbon were determined from filter samples collected using the 
ASACA PCM. In addition, data on these species, as well as from elemental analyses, 
were available from the nearby (approximately 30 m) monitoring site run by the Georgia 
Environmental Protection Division (GaEPD), which is also reported as part of the US 
EPA Air Quality System.  While the ASACA data (and the filters used) are available 
every day during the period, the GaEPD samping is done every third day.  Table 5.1 
summarizes the composition of these components from our filters as well as the data 
reported in AQS. The ionic and carbonaceous composition of the PM obtained from the 
nylon and Teflon filters shows that the bulk of the PM was sulfate and organic carbon 
(Table 5.1), with a significant fraction being elemental carbon. It is important to note that 
both our collected data and the reported data are highly similar and show approximately a 




Table 5.1: Average Comparison of AQS and ASACA Particle Composition for  
Species of Interest 
 
 
A more complete presentation of the PM composition, including elemental 
concentrations observed at the GaEPD site and a comparison of the average ionic and 
carbonaceous PM concentrations for daily (e.g., corresponding to the samples used in the 
cellular exposure study) versus 1-in-3 day sampling (as used for the source 
apportionment) is contained in Appendix A. 
 
 
Figure 5.1: Major studied components of particulate matter are in agreement with 
previously reported measurements. Teflon filters from the South Dekalb area were 
collected and analyzed for ammonium, nitrate, sulfate, organic carbon, and elemental 
carbon. These results were compared to data from the Air Quality System for a similar 
sampling region. Our composition shows a nearly 1:1 agreement with the AQS data.  
	  
	   SD AQS Data (ug/m3) ASACA Data (ug/m3) 
	  
NH4 NO3 SO4 OC EC NH4 NO3 SO4 OC EC 
           
Average 1.22 0.73 3.86 4.70 0.95 1.40 0.65 4.12 4.92 0.80 
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Source Apportionment Modeling of PM2.5  
Measurements were used to conduct Chemical Mass Balance (CMB) source 
apportionment for the days that coincided with the samples used in this analysis as 
previously described (165) and where GaEPD data was available (i.e., every third day).  
The reason for conducting source apportionment when the GaEPD data is available is the 
need to have elemental species concentrations.  The good agreement between the 
ASACA and GaEPD sampling, and their close proximity, suggest they are sampling from 
very similar air masses, and that the source apportionment conducted using the 
concentrations observed at the GaEPD site are applicable for the filters collected as part 
of the ASACA monitoring.  On average, the most prominent sources for the resulting 
particulate matter were ammonium sulfate and bisulfate, largely due to coal burning in 
the region, which together comprised 38%, biomass burning at 20%, gasoline-fueled 
vehicles at 8%, and diesel vehicles at 9%.  These results are summarized in Table 5.2.  
This source distribution is expected as coal is a major fuel-stock for electricity 
generation, the sampling site is near two freeways and the March-April months are when 
prescribed fires are most common in the Southeast.   
 






GV	   DV	   DUST	   BURN	   COAL	   AMSULF	   AMBSULF	   AMNITR	   SOC	  
	   	   	   	   	   	   	   	   	   	  
AVERAGE	   10.01%	   6.86%	   4.70%	   11.06%	   0.83%	   18.65%	   26.64%	   9.06%	   12.19%	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Results from the particle analysis show that the composition was primarily sulfate, 
related ammonium, and organic carbon, with smaller amount of elemental carbon, and 
that the primary sources were those leading to sulfate, biomass burning and mobile 
sources.  
RLE-6TN cells are viable up to a concentration of 10ug/cm2 of PM2.5 
RLE-6TN cells were plates in 6 well plates at a density of 100,000 cells / cm2 and 
allowed to attach for 24 hours, then treated with increasing concentrations of isolated 
PM2.5 for 24 hours. PM2.5 was isolated from the Teflon filters and diluted in cell culture 
media to concentrations of 0.01ug/cm2, 0.1ug/cm2, 1ug/cm2, 5ug/cm2, 10ug/cm2, 
25ug/cm2, and 50ug/cm2. These concentrations were picked based on previous literature 
suggesting these concentrations are generally within physiologically relevant ranges and 
that anything over 100ug/cm2 has been shown to be toxic to cells (cite). After culture for 
24 hours, the cells from each PM2.5 concentration group were trypsinized and 
resuspended in a 1:1 suspension with trypan blue. The suspension was analyzed by 
counting dead cells, which were stained blue, and normalizing to the total number of cells 
in each group.  
As shown in Figure 5.2, over 99% of cells were viable up to a concentration of 
10ug/cm2. When the concentration was increased to 25ug/cm2 and 50ug/cm2, cell 
viability began to decline rapidly to only 83% and 56% of viable cells, respectively. From 
these viability results, a low, medium, and high concentration of PM2.5 exposure were 
chosen to explore in further studies. PM2.5 was isolated from the Teflon filters and added 
to cell culture media at 0.1ug/cm2, 1ug/cm2, and 10ug/cm2 for all of the following 
described experiments.  
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Figure 5.2: RLE-6TN cells are viable up to a concentration of 10ug/cm2. RLE-6TN 
cells were cultured with increasing concentrations of isolated PM2.5 for 24 hours and 
analyzed using the trypan blue assay. Approximately 100% of cells were viable through a 
concentration of 10ug/cm2. Treatment with concentrations above 10ug/cm2 resulted in 
significant cell death. * (p < .01) 
 
Addition of PM2.5 results in elongated cells and decreased circularity 
In order to explore how exposure of RLE-6TN cells to PM2.5 in a range of 
different elastic moduli environments affects cell morphology, cells were cultured of 
polyacrylamide gels of varying substrate stiffness (2-24kPa) with or without the addition 
of PM2.5 at 10ug/ cm2, 1ug/ cm2, or 0.1ug/ cm2 for five days. The cells were then fixed 
and stained with Texas Red-X conjugated phalloidin to visualize any changes in the actin 
cytoskeletal organization. Cells cultured on soft substrates and on Ln-coated glass 
without the addition of PM2.5 displayed the typical rounded epithelial morphology and 




Figure 5.3: Addition of PM2.5 results in elongated cells and staining for stress 
fibers. RLE-6TN cells were cultured on Fn-PA gels or Fn- or Ln-coated glass for 5 days 
with the addition of 10ug/cm2, 1ug/ cm2, or 0.1ug cm2 concentrations of PM2.5, and 
changes in the actin cytoskeleton were analyzed by staining actin filaments. Experiments 
were performed in triplicate, representative images are presented.  
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As substrate stiffness was increased, cells displayed a subsequent elongated morphology 
and thick, aligned actin filaments indicative of stress fibers. In addition, when PM2.5 was 
added to the cultures, most notably at the 10ug/ cm2 concentration, cells exhibited 
enhanced staining for actin filament stress fibers. Notably, cells cultured on 8 kPa gels 
showed a considerable increase in actin fibers and cell elongation with the addition of 
PM2.5 when compared with matched substrate-stiffness controls (Figure 5.3, panel B). 
This substrate stiffness is of particular interest because it most closely matches that of 
slightly fibrotic lung tissue, indicating that PM2.5 may have more marked effects on a 
lung that is undergoing fibrotic remodeling. In addition, this increase appeared to be 
concentration dependent, with a slightly more cell elongation and stress fiber formation 
seen at the 10ug/ cm2 concentration compared to 1ug/cm2 and 0.1ug/cm2 concentrations.  
 Finally, cell circularity was calculated to quantify differences in the observed cell 
shape. Values closer to 1 indicate a more rounded, epithelial like cell (Figure 5.4).  
Statistical significance is shown for each experimental group in comparison to its same 
substrate stiffness group with no PM2.5 added. These results show that the addition of 





Figure 5.4: Cell circularity decreases when cultured with the addition of PM2.5. 
RLE-6TN cells were cultured on polyacrylamide gels of increasing stiffness, Fn or Ln 
coated glass. PM2.5 was added at varying concentrations for 5 days. Cells were fixed 
stained with Texas-red phalloidin to visualize the actin cytoskeleton and circularity 
analyzed. Values closer to 1 indicate a more rounded, epithelial like cell.  
 
Increased cell elongation and stress fibers coincide with increased cell stiffness 
Based on the observation that PM2.5 resulted in decreased cell circularity and 
increased stress fiber formation, most notably at the 8kPa substrate stiffness, it was 
investigated if these phenotypic observations coincided with an increase in cell stiffness. 
Previous studies have linked increased epithelial cell stiffness in increased substrate 
stiffnesses environments that are commonly seen during pulmonary fibrosis. 
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Furthermore, several studies have linked increased cell stiffness with increased cell 
contractility and TGF β activation (29).  
Therefore, to explore if the addition of PM2.5 increased cell stiffness, RLE-6TN 
cells were cultured on Fn-cross-linked 8 kPa gels with the addition of 10ug/cm2 , 1ug/ 
cm2 , 0.1ug cm2 , or no PM concentrations of PM2.5 and cell stiffness was measured by 
atomic force microscopy (AFM). It was observed that there was a concentration 
dependent increase in cell-stiffness with the addition of increasing amounts of PM2.5 
when compared to the 8-kPa control. When cells were cultured with the addition of either 
10ug/cm2 or 1ug/ cm2 concentrations of PM2.5, cortical cell stiffness was raised (average 
Young’s Moduli of 2.8 kPa and 2.4kPa respectively) over cells that were cultured with 
the 0.1ug/ cm2 concentration of PM2.5 or no addition of PM2.5 (Average Young’s 
moduli of 1.5 kPa and 1.4 kPa respectively). Statistical significance is shown in 
comparison to the no PM2.5 added control (Figure 5.5). These results indicate that the 
addition of PM2.5 increases cell stiffness and agrees with the increase in cortical actin 
stress fibers and decreased circularity observed (Figure 5.3, panels B, F, J, N, and 
Figure 5.4).  
Alveolar epithelial cells display increased TGFβ activation with the addition of PM2.5  
 Previous studies have shown that elevated levels on cell stiffness can lead to 
contractile forces by ultimately enabling the activation of latent TGFβ, a primary EMT 
inducer. Since we saw increases in cell-stiffness with the addition of PM2.5, we 
investigated if the addition of PM2.5 also resulted in differences in TGFβ activation, 
which could lead to further increased EMT events. To determine if addition of PM2.5 to 
alveolar cells on differing substrate stiffnesses induced TGFβ activation, the mink lung 
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epithelial reporter cell (MLEC) bioluminescence co-culture assay was performed for each 
PM2.5 concentration. Similar to the cell morphology experiments, RLE-6TN cells were 
cultured on PA gels ranging from 2-24 kPa with or without the addition of each 
concentration of PM2.5. In controls without the addition of PM2.5, alveolar epithelial 
cells were found to increasingly activate TGFβ in response to increases in substrate 
stiffness. As expected, the control groups cultured on Fn-coated glass exhibited high 
levels of TGFβ activation, while those cultured on Ln-coated glass showed significantly 
less levels. When PM2.5 was added to the cultures for 5 days, the cells were found to 
activate significantly greater amounts of TGFβ in a dose dependent manner (Figure 5.6).  
 Of particular interest was the comparison of TGFβ activation across the PM2.5 
concentrations at 8 kPa, a physiologically relevant stiffness during the progression of 
human lung fibrosis. At this substrate stiffness with the addition of PM2.5, we observed 
an increase in TGFβ activation similar to what was observed on high substrate stiffness 
and Fn-coated glass without the PM2.5. PM2.5 addition to a solution of inactive TGFβ 
was found insufficient to activate TGFβ strongly suggesting that increases in TGFβ 
activation observed are mediated by the cells. Statistical significance is for each 













Figure 5.5: RLE-6TN cell stiffness increases on same substrate stiffness with the 
addition of PM2.5. RLE-6TN cells were cultured for 5 days on 8kPa polyacrylamide 
gels with or without the addition of PM2.5. Single cell elasticity was measured with AFM 
nanoindentation to characterize cell stiffening in response to substrate stiffness and 
PM2.5.  Averages of cell stiffness for each PM2.5 concentration are presented. 













Figure 5.6: Stiffness-mediated activation of TGFβ  is increased by addition of 
PM2.5.  RLE-6TN cells were cultured for 5 days on substrates of increasing stiffness 
with or without the addition of each concentration of PM2.5 and levels of TGFβ 
activation were determined using the MLEC bioluminescence co-culture assay. Statistical 
significance is shown for each concentration of PM2.5 within its same substrate stiffness 






Addition of PM2.5 exacerbates stiffness-mediated EMT  
 As described throughout this work, TGFβ is a potent inducer of EMT. In this 
work, we have shown that the addition of PM2.5 results in an elongated cellular 
phenotype that displays actin stress fibers, increased cortical cell stiffness, and increased 
TGFβ activation. Therefore, experiments were performed to confirm that these 
characteristics also coincide with increased EMT. As described in the previous 
experiments, RLE-6TN cells were cultured on increasing substrate stiffness PA gels with 
or without the addition of each concentration of PM2.5 for 5 days and analyzed for EMT 
responses by immunohistochemistry (Figure 5.7) and western blotting (Figure 5.8, 5.9). 
As previously mentioned, alveolar epithelial cells undergo EMT on Fn-coated glass while 
they maintain an epithelial phenotype on Ln-coated glass coverslips. These conditions 
were used as controls. As expected, EMT was observed on Fn-coated glass as indicated 
by high expression of alpha-smooth muscle actin (α-SMA) and low levels of e-cadherin 
at cell-cell contacts. Conversely, cells cultured on Ln-coated glass showed an epithelial 
phenotype as indicated by low levels of α-SMA and maintenance of expression of e-
cadherin at cell-cell contacts (Figure 5.7).  
Cells cultured without PM2.5 that were stained for either epithelial or 
mesenchymal markers after 5 days, showed a loss of epithelial markers and subsequent 
gain of mesenchymal markers as substrate stiffness was increased. This effect was 
enhanced with the addition of PM2.5. Figure 5.9 demonstrates that when PM2.5 was 
added at a 10ug/cm2 concentration, the alveolar cells showed an increase in the 
expression of α-SMA at lower substrate stiffnesses when compared to stiffness-matched 
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controls (no PM2.5 added). In addition, there appears to be a concentration threshold of 





Figure 5.7. Alveolar epithelial cells show enhanced α - SMA staining in response to 
PM2.5 exposure. RLE-6TN cells were cultured on Fn-PA gels or Fn- or Ln-coated glass 
for 5 days with the addition of 10ug/cm2, 1ug/ cm2, or 0.1ug cm2 concentrations of 
PM2.5. Cells were fixed and immunohistochemistry for e-cadherin (epithelial) and α - 
SMA (mesenchymal) was performed. Experiments were performed in triplicate, 




Figure 5.8. Analysis of epithelial protein markers with the addition of PM2.5. RLE-
6TN cells were cultured in increasing substrate stiffnesses with or without the addition of 
each concentration of PM2.5 and analyzed for changes in e-cadherin (A) and cytokeratin 
(B) protein levels. Three independent triplicate experiments were performed and 




Figure 5.9. Analysis of mesenchymal protein markers with the addition of PM2.5. 
RLE-6TN cells were cultured in increasing substrate stiffnesses with or without the 
addition of each concentration of PM2.5 and analyzed for changes in alpha-smooth 
muscle actin (A) and prolyl-4-hydroxylase (B) protein levels. Three independent 
triplicate experiments were performed and significance is shown for each group 
compared to the same treatment on 2kPa gel. (* p< 0.1) 
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Exposure to PM2.5 results in increased TGFβ activation without cell contractility 
The results thus far have indicated that exposure of RLE-6TN cells to PM2.5, 
most significantly at concentrations of 10ug/cm2, result in phenotypes consistent with 
EMT. Briefly, cells exhibit increase stress fiber formation, increased cell stiffness, 
increased TGFβ activation, and simultaneous down regulation of epithelial protein 
markers and up regulation of mesenchymal markers. EMT is highly dependent on cell 
contractility, allowing for a mechanically driven activation of TGFβ that subsequently 
drives EMT. Therefore, the MLEC assay that measures TGFβ activation was performed 
again with the same protocol but with the addition of the ROCK contractility inhibitor Y-
27632 during the 5-day culture.  
In the presence of the contractility inhibitor, Y-27632, cells that were not treated 
with PM2.5 activated low levels of TGF β despite what substrate stiffness they were 
cultured on. However, there were significant increases in TGF β activation with the 
addition of 10ug/cm2 PM2.5 on all substrate stiffnesses (Figure 5.10). These results 
suggest that inhibition of cell contractility is sufficient to inhibit substrate mediated TGF 
β activation, but not sufficient to inhibit TGF β activation mediated by the exposure of 
PM2.5. A control where PM2.5 was added to a solution of inactive TGFβ was found 
insufficient to activate TGFβ, again suggesting that these increases in TGFβ activation 
observed due to PM2.5 are still mediated by the cells, just not by cell contractility. This 
data indicates that there may be a second, non-mechanical mechanism of TGFβ activation 











Figure 5.10: TGFβ Activation is only partially mediated by cell contractility with 
PM2.5 exposure. RLE-6TN cells were cultured in each condition with the addition of the 
ROCK inhibitor, Y-27632, for 5 days and analyzed for TGFβ activation using the MLEC 
assay. Statistical significance is reported for differences between same substrate stiffness 








FnIII9*10 reduces TGFβ activation caused to PM2.5 and substrate - stiffness 
Data presented previously suggested that engagement of the matrix through α3/α5 
integrins could mediate EMT events, notably TGF β activation, even on increased 
substrate stiffnesses. Therefore, it was investigated if this observation still held true when 
the cells were exposed to PM2.5. RLE-6TN cells were cultured on PA-gels ranging from 
2 to 24 kPa that were cross-linked with either FnIII9*10 (predominant α3 integrin 
engagement) or FnIII94G10 (predominant αv integrin engagement) with or without the 
addition of 10ug/cm2 PM2.5.  
When RLE-6TN cells exposed to PM2.5 were also cultured on the FnIII9*10 
variant, there was a partial reduction in TGFβ activation, but not to the level observed 
without any PM2.5 exposure (Figure 5.11, A). Significance is shown for comparisons 
between PM2.5 added groups with or without culture on the Fn variant. This further 
suggests that there is a secondary mechanism activating TGFβ due to exposure of cells to 
PM2.5. Interestingly, when cells were cultured on the FnIII94G10 variant, similar levels 
of TGFβ activation were observed with and without the addition of PM2.5 (Figure 5.11, 
B). This similar activation profile suggests that there is a maximum level of TGFβ that 




Figure 5.11: FnIII9*10 significantly reduces the effect on substrate-stiffness + 
PM2.5 activation of TGFβ. RLE-6TN cells were cultured on 1) Fn-coated PA gels of 
increasing substrate stiffness 2) Fn-coated PA gels with the addition of 10ug/cm2 PM2.5, 
3) Fn-variant coated PA gels, or 4) Fn-variant coated gels with the addition of 10g/cm2 
PM2.5 and analyzed for levels of TGFβ activation using the MLEC assay. Significance is 
shown for comparisons between the PM2.5 added groups with or without culture on the 
Fn variant. (* p < .01) 
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Exposure of RLE-6TN cells to PM2.5 results in increased levels of ROS 
 
Finally, it was hypothesized that the observed additional activation of TGF β 
when cells were exposed to PM2.5 was due to intracellular production of reactive oxygen 
species. In order to explore this hypothesis, RLE-6TN cells were cultured on PA gels of 
increasing substrate-stiffness with or without exposure to 10ug/cm2 of PM2.5 and 
analyzed by the DCFH2-DA assay, which measures total levels of intracellular ROS. On 
each different group of gel stiffnesses, an increase in ROS was observed with the addition 
of PM2.5 (Figure 5.12). Interestingly, there was an increase in ROS solely due to 
increased substrate stiffness (no PM2.5 added). This suggests that increased tissue 
stiffness commonly seen in pulmonary fibrosis patients likely results in increased 
intracellular ROS levels and that exposure of the distal lung to PM2.5 significantly 
increases these levels of ROS.  
 
Figure 5.12: Exposure of RLE-6TN cells to PM2.5 increases intracellular ROS. 
RLE-6TN cells were cultured on PA gels of increasing substrate stiffness with or without 
10ug/cm2 PM2.5 and intracellular ROS levels were measured by the DCFH2-DA 
oxidation assay. * (p < .01) 
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ROS levels are mediated by treatment with antioxidants NAC and glutathione 
Several studies have suggested antioxidants including N-acetyl-cysteine (NAC) 
and glutathione, may be effective in decreasing levels of ROS within lung tissue. 
Therefore, it was explored if treatment with NAC or glutathione was able to decrease the 
increase in ROS that was observed due to the exposure of cells to PM2.5. Similar to the 
previous experiment, RLE-6TN cells were cultured on increasing substrate stiffnesses 
with or without the addition of PM2.5 In addition, groups with PM2.5 added were either 
treated with NAC or glutathione. For each of the experimental groups, treatment with 
either NAC or glutathione drastically reduced the levels of intracellular ROS observed 
with exposure to PM2.5 (Figure 5.13). Notably, on higher substrate stiffnesses, i.e. 16 
and 24 kPa, these antioxidants were able to reduce the ROS levels below the levels seen 
without the addition of PM2.5. This suggests that substrate stiffness alone is capable of 
inducing increases in intracellular ROS, and that this effect can be mitigated by treatment 
with these antioxidants.  
 
Figure 5.13: The antioxidants NAC and glutathione reduce intracellular ROS levels. 
RLE-6TN cells were cultured on 2-24 kPa gels with or without 10ug/cm2 PM2.5 and 
treatment with either NAC or glutathione. Three independent triplicate experiments were 
performed and significance is shown for antioxidant groups in comparison to PM2.5 
treated cells at each substrate stiffness. * (p < .01) 
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α3 integrin engagement and N-acetyl-cysteine treatment abrogate increased levels of 
TGFβ activation due to increased substrate stiffness and PM2.5 exposure 
 Previous data and the experiments thus far have strongly suggested that increased 
substrate stiffness is able to induce cell contractility leading to mechanical activation of 
TGFβ and that cellular engagement of the matrix through a3 integrin can reduce this 
increased activation. Furthermore, when alveolar epithelial cells are exposed to PM2.5 
there were even further increases in TGFβ activation than were seen on increased 
substrate stiffness alone. Finally, exposure to PM2.5 results in increased intracellular 
ROS levels, suggesting a possible second mechanism of TGFβ activation through 
oxidation of the LAP.  It was found these increased levels of ROS could be drastically 
reduced with antioxidant treatments.  
 It was hypothesized that by altering the biochemical properties of the matrix to 
engage α3 integrin by utilizing the FnIII9*10 variant, while also treating the cells with 
NAC, TGFβ activation levels could be decreased to a level seen on laminin (i.e. levels 
seen from healthy epithelial cells). RLE-6TN cells were cultured on polyacrylamide gels 
of increasing substrate stiffness under several conditions: 1) Fn, 2) FnIII9*10, 3) Fn + 
10ug/cm2 PM2.5, 4) FnIII9*10 + 10ug/cm2 PM2.5, 5) Fn + 10ug/cm2 + NAC, and 6) 
FnIII9*10 + 10ug/cm2 + NAC. TGFβ activation levels for the first four groups closely 
matched the results previously seen. Cells cultured on full length Fn with PM2.5 that 
were treated with NAC had decreased levels of TGFβ activation compared to cells 
cultured on Fn and PM2.5, but not a complete reduction to the level seen from cells 
cultured on Ln or 2 kPa. When cells were cultured on the FnIII9*10 and were treated 
with NAC, there was a complete reduction in TGFβ to levels similar to cells cultured on 
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Ln despite what substrate stiffness they were cultured on (Figure 5.14). These results 
taken together strongly suggest that increased tissue stiffness results in increased cell 
contractility and a preference to engage the matrix through αv integrin, which 
mechanically activates TGFβ; while exposure to PM2.5 further increases this TGFβ 
activation by increasing intracellular ROS and oxidizing the LAP. These events appear to 
have an additive effect on the activation of TGFβ and result in the significant increases 
observed in EMT events.  
 
 
Figure 5.14: FnIII9*10 and NAC treatment restore low levels of TGFβ activation 
seen on epithelial maintaining substrates. RLE-6TN cells were cultured on increasing 
substrate stiffnesses with or without the epithelial maintaining variant FnIII9*10 cross 
linked to the surface and exposed to PM2.5 with or without treatment with the 




EMT has been implicated as a critical process in the progression of invasive 
pathologies such as pulmonary fibrosis. Therefore, it is imperative that the process is 
fully understood in different pathological conditions in order to give insight for future 
therapeutic options. Several studies have previously shown that the micromechanical 
environment that alveolar epithelial cells interact with is a strong driving force for 
activating TGFβ and driving EMT by itself. Here it was shown that in addition to 
increased tissue stiffness, exposure to environmental stimuli, such as PM2.5, is involved 
in further increasing TGFβ and driving EMT events.  
Immunohistochemistry, cell phenotypic analyses, and western blotting for EMT 
protein markers, show that at higher concentration of PM2.5 (10ug/cm2), mesenchymal 
markers are more highly expressed on lower substrate stiffness, which lacked 
mesenchymal marker expression before PM2.5 treatment. In addition, it was observed 
that PM2.5 was involved in the increase of epithelial cell cortical stiffness. This increase 
in cortical cell stiffness was hypothesized to lead to cell contraction, which can in turn 
mechanically activate the cytokine TGFβ, which is known to be a potent inducer of EMT. 
Experiments were performed where cell contractility was blocked by the ROCK inhibitor 
Y-27632 and TGFβ activation was measured by the MLEC assay. Interestingly, when 
cells were treated with 10ug/cm2 PM2.5, inhibition of cell contractility was able to 
decrease TGFβ activation levels, but not to the level seen without PM2.5 exposure. This 
indicates that there is a second mechanism, not dependent on cell contraction and 
mechanical stimulus, with which TGFβ is activated in response to PM2.5 exposure. The 
hypothesis that a second mechanism of TGFβ activation is involved was further 
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confirmed by studies where alveolar epithelial cells exposed to PM2.5 were cultured on 
the α3 engaging matrix variant FnIII9*10. Similar results were observed to the cell 
contractility inhibitor study, where the FnIII9*10 variant was able to decrease TGFβ 
activation, but not to a level observed without the addition of PM2.5, further suggesting 
that PM2.5 activates TGFβ by a secondary, non-mechanical mechanism.  
The alveolar epithelium forms a continuous, highly regulated physical barrier, 
which serves as a protector against inhaled environmental agents, including PM2.5. 
During EMT, the tight cell junctions and E-cadherin expression commonly seen in the 
epithelium are lost. This loss of structure has been implicated in the allowance of 
enhanced signaling between the epithelium and underlying immune cells (166). Previous 
studies have implicated enhanced immune cell activation and inflammation in the release 
of ROS that leads to the activation of TGFβ, (89, 98, 99, 167) and TGFβ itself is known 
to be able to induce ROS production as part of its signal transduction pathway. Therefore, 
ROS were determined to be a likely culprit for the further increase in TGFβ activation 
that was observed that could not be abrogated by the inhibition of cell contractility. First, 
total levels of intracellular ROS with or without the addition of 10ug/cm2 PM2.5 were 
measured on substrate stiffnesses ranging from 2 to 24 kPa. Significant increases in ROS 
were observed on each substrate stiffness when cells were exposed to PM2.5 
Interestingly, as substrate stiffness was increased, there was a decreased difference 
between the non-treated and PM2.5 added groups. This indicated that substrate stiffness 
alone likely has an effect on increasing ROS levels. Next, it was explored if treatment 
with common antioxidants could decrease the levels of ROS observed with PM2.5 
exposure. When the cells were treated with either NAC or glutathione in conjunction with 
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PM2.5 exposure, ROS levels were significantly decreased. Notably, on stiffer substrates, 
the antioxidant treatment decreased intracellular ROS to levels lower than seen on the 
matched substrate stiffness without the addition of PM2.5. This data further suggested 
that substrate stiffness alone is capable of increasing levels of ROS.  
A recent pulmonary fibrosis drug trial that utilized treatment with the antioxidant 
N-acetyl-cysteine showed some benefit in delaying the progression of pulmonary 
fibrosis, but was not able to restore lung function or reverse any damage currently present 
(152). From the data presented, it is not surprising that NAC treatment alone was not a 
fully successful treatment, since it has clearly been shown that the mechanical 
environment is a crucial mediator of TGFβ activation, progression of EMT, and the 
subsequent onset of a fibrotic scar. Therefore, in a final experiment, it was explored if 
combinatorial treatment with the antioxidant NAC in conjunction with engagement of the 
epithelial maintaining matrix variant FnIII9*10, could mediate the significantly increased 
levels of TGFβ activation previously observed with epithelial cells cultured on increased 
substrate stiffness and exposed to PM2.5. When alveolar epithelial cells were cultured on 
FnIII9*10 and treated with NAC, levels of TGFβ were decreased to levels seen from cells 
cultured on laminin, the known epithelial maintaining substrate. This level of TGFβ 
activation was seen despite the stiffness of the substrate that cells were cultured on. This 
final piece of data strongly suggests that TGFβ activation is mediated by a combination 
of mechanical stimuli, i.e. tissue stiffness, and changes in the intracellular levels of ROS. 
Importantly, this result starts to explain why the clinical trial utilizing treatment with 
NAC alone was not highly effective.  
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This work shows that alveolar epithelial cells exhibit increased cell stiffness, 
TGFβ activation, and EMT events in response to PM2.5 exposure. These results highlight 
the importance of studying not only the micromechanical environment in lung disease but 
also the exposure to environmental injury adjuvants in already diseased lung models. 
Previous findings have indicated that increased tissue stiffness is able to lead to increased 
cell contraction, TGFβ activation, and subsequent EMT and represents one of the initial 
stages of pulmonary fibrosis (58, 61). Here these findings are expanded and show that in 
addition to the delicate balance between ECM stiffness, TGFβ, and EMT, exposure to 
environmental stimuli, such as PM2.5, additionally mediates this interaction through 
increased levels of intracellular ROS. Furthermore, it appears that there is an additive 
effect on TGFβ activation from mechanical stimuli and ROS from environmental stimuli, 
resulting in significantly increased EMT events.  
Finally, it is shown that by controlling both the micromechanical environment 
through a3 integrin engaging substrates and reducing intracellular levels of ROS, that 
TGFβ activation can be reduced to levels typically seen in healthy epithelial cells. This 
work suggests that PM2.5 has a role in additionally driving a pre-existing fibrotic 
phenotype in pulmonary cells and that approaches to treat pulmonary fibrosis must focus 
on controlling both the micromechanical stimuli presented to alveolar epithelial cells 
while also controlling the oxidative effect of increased ROS. Future work should focus on 
further elucidation of the pathways that both tissue stiffness and PM2.5 engage to initiate 
the EMT program and additionally how these pathways intersect in order to develop 





Idiopathic pulmonary fibrosis is a chronic, progressive, untreatable disease, 
characterized by the emergence of mesenchymal cells and alterations in the ECM that 
result in increased tissue stiffness. Classically, changes in the ECM have been considered 
the final result of fibrosis. However, recently a much more active role for the ECM is 
starting to emerge. Both the biophysical and biochemical properties of the matrix can 
influence cellular processes relevant in the development of fibrosis, such as the 
emergence of a myofibroblastic population through EMT.   
Specifically, the mechanical properties of the fibrotic ECM have the ability to 
affect cell behavior. In fibrosis, there is a notable increase in tissue stiffness, largely due 
to the deposition of increased amounts of unstructured extracellular matrix proteins as 
well as increased crosslinking of collagen and elastin due to an up regulation of lysyl 
oxidase.  Numerous studies have shown that this increased matrix rigidity results in cells 
matching their cytoskeletal tension to their external environment and activating increased 
levels of latent TGFβ, the potent inducer of EMT (29, 30). Interestingly, cellular 
fibronectin binds to lysyl oxidase with high affinity (99) and crosslinking of the matrix by 
lysyl oxidase producing ROS, which can in turn activate TGFβ (95, 98). In addition, 
biochemical changes, such as the emergence of a provisional matrix composed 
predominantly of fibrin-fibronectin during wound healing and pathogenesis can lead to 
marked changes in cell behavior and phenotype. Studies from Kim et al showed that in 
vitro, ATII cells undergo spontaneous EMT in response to fibrin-fibronectin matrices but 
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not in response to laminin-collagen matrices through a mechanism involving αvβ6 
integrin mediated activation of TGFβ (142). Furthermore, here it is shown that variations 
in the 9th and 10th type III repeats of fibronectin that closely model folded or unfolded 
states of Fn, determine integrin specific cell attachment, and result in marked cellular 
phenotype differences. Notably, cells that predominantly attach and engage the 
underlying matrix through α3 integrins (FnIII9*10) maintain a rounded, epithelial 
morphology, while predominantly αv integrin engagement (FnIII4G10) results in 
elongated cells and intense actin staining typical of more mesenchymal-like cells. Taken 
together, it is clear that during the development of fibrosis, the cells and the matrix form 
an interactive system. This reciprocal interaction between the matrix properties and the 
cell may result in a positive feedback loop; amplifying fibrotic disease progression. By 
understanding the fine control of the biophysical and biochemical properties of the matrix 
and how they interact together to control cell phenotype, new, targeted therapeutics for 
pulmonary fibrosis may be developed that are more effective.  
In Aim 1 of this work it is shown that both the biochemical and biophysical 
properties of the ECM play a role in activation of the EMT program. Interestingly, the 
data suggest that neither the conformation of Fn nor the substrate rigidity is fully a 
dominant effector of EMT and that there appears to be an integrated response to 
combinations of integrin engagement and compliance matching. The first major 
contribution of this work is the finding that while increased tissue rigidity can induce 
TGFβ activation and subsequent EMT, integrin specificity can highly modulate this 
response. Most notably, it is shown that on stiff matrices with elastic moduli in the range 
of fibrotic lung tissue (16 kPa), that sustained α3β1 integrin engagement by ATII cells, 
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results in low levels of TGFβ activation and maintenance of an epithelial phenotype, 
despite the increased tissue stiffness. Alternatively, cells cultured on soft matrices that 
engage αv integrins, activate increased levels of TGFβ and undergo EMT. From a 
therapeutic standpoint, these results suggest that a simple option for fibrosis treatment 
would be administration of a αv-blocking antibody. However, a major difficulty with this 
approach is the large chance of side effects, due to the ubiquitous expression and function 
of αv integrins within human tissues. Although more complicated, a possible effective 
solution may be to target the conformation of Fn in the underlying matrix in order to 
stabilize the integrin binding domains in the 9th and 10th type III repeats. As shown in this 
work, this would result in sustained α3β1 integrin engagement and maintenance of an 
epithelial phenotype halting ECM production and concomitant tissue stiffening. 
  In addition to therapeutic options, the results presented here have large 
implications on biomaterial design. Biomaterials often elicit fibrotic responses, which are 
characterized by excessive deposition of ECM and stiffening of the surrounding tissue, 
exhibiting many similarities to other fibrotic pathologies, including pulmonary fibrosis. 
The literature has clearly shown that EMT occurs in response to increasingly rigid 
materials, likely perpetuating the fibrotic response and further stiffening the tissue. 
Therefore, to design effective materials, minimizing this response is desirable. This work 
suggests that addition of engineered ECM variants, such as the FnIII9*10 fragment, on 
the surface of the biomaterial may be able to modulate the formation of a fibrotic capsule 
commonly seen after implantation.  
 Additionally, these results lend themselves to applications for directing cell fate in 
tissue regeneration applications. Although this work has highlighted the role of EMT in 
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pathological progression, it is also known to be an important transition in development 
and regeneration of several tissues. The finding that epithelial cells can undergo EMT on 
soft substrates with the proper integrin engagement may lead to interesting approaches 
for biomaterial design. Specifically, these integrin specific fragments could be exploited 
in tissue engineering applications that aim to create complex tissues where epithelial and 
mesenchymal cells need to be in close proximity. For example, a soft biomaterial could 
be patterned with both the epithelial promoting variant (FnIII9*10) and the mesenchymal 
promoting fragment (FnIII94G10) in distinct spatial orientations. This further 
understanding of the interaction between the biophysical and biochemical properties of 
the matrix is a first step to developing new therapeutic options and novel tissue 
engineering strategies.   
 It is evident that major alterations in the ECM of the lung during the onset and 
progression of fibrosis are pivotal in directing cell fate through cellular processes such as 
EMT. However, alterations in the matrix are not the only factors involved in the 
progression of fibrotic diseases. Notably, the tissue of the lung is distinctive from many 
other epithelial tissues due to its high exposure to damaging stimuli from environmental 
components and these components have been linked to the progression of pulmonary 
disease. The work in this dissertation shows that in addition to increased matrix rigidity, 
repeated injury to ATII cells by exposure to PM2.5 further increases TGFβ and EMT and 
that this response is in part due to increased levels of ROS. Interestingly, it is shown that 
ATII cells cultured in the presence of PM2.5 on soft matrices exhibited increased 
contractility, TGFβ activation, and underwent EMT. It was hypothesized that the α3 
engaging matrix variant FnIII9*10 would be able to modulate this response. However, it 
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was observed that culture on FnIII9*10 resulted in a decrease in the increased TGFβ 
activation levels, but not to the level seen without PM2.5 exposure, suggesting that there 
is likely an additional mechanism of TGFβ activation that acts synergistically to further 
drive EMT. The results further indicate ROS are increased not only in response to PM2.5 
exposure, but also increased matrix rigidity. These findings are critical because ROS have 
been reported to activate TGFβ on their own. This suggests a paradigm connecting 
exposure of PM2.5 and the progression of lung fibrosis where initial insults of injury 
from PM2.5 would set off an inflammatory response, recruiting matrix-producing 
fibroblasts while also raising ROS levels allowing for latent TGFβ activation and 
subsequent ATII cell EMT. This initial cascade would result in a significantly increased 
population of cells laying down an abundance of ECM, ultimately increasing the matrix 
rigidity. This increase in rigidity would then be sensed by surrounding epithelial cells, 
resulting in additional EMT, leading to more ECM producing fibroblasts which would 
further drive the fibrotic diseased state (Figure 6.1). This information stresses the need to 
focus on the presence of positive feedback loops that amplify cell and matrix changes in 
both basic biologic studies as well as in the design of therapeutics for fibrotic diseases. 
Specifically, targeting at the level of this reciprocal cell-matrix interaction may lead to 
more effective treatments that focusing on the properties of the cell or microenvironment 
alone. Future studies that measure specific changes in matrix production due to exposure 










Figure 6.1. Schematic of positive feedback interactions that contribute to the 
progression of lung fibrosis. Initial insults of injury and αv integrin engaging matrices 
can activate latent TGFβ driving EMT. This process leads to further changes of the 
biochemical and biophysical properties of the matrix, which can drive cell contractility 






In patients, IPF is diagnosed at a late stage of disease progression due to the lack 
of symptoms until the lungs lose vital capacity. Due to this late diagnosis, the etiology of 
IPF is largely unknown, specifically about earlier stages of the disease. These studies 
focus largely on how already altered matrix properties drive ATII cell phenotype and the 
progression of fibrosis. While these studies have implications in halting the progression 
of fibrosis, future studies focused towards understanding earlier stages of the disease may 
have more promise towards completely healing those with IPF.  In this work it is shown 
that there is a delicate balance between the properties of the matrix, ATII cell injury, and 
EMT. It appears that there is a threshold of these signals that must be met to drive EMT. 
We can speculate that a similar threshold may need to be met to initiate fibrosis, such that 
there may be light, transient states of fibrosis that are able to be resolved as well as 
progressive states of fibrosis that actually present in the clinic. It can be hypothesized that 
the progressive fibrosis may be a result of more severe and/or repeated injury events 
where a certain threshold of signals stimulates a strong positive feedback loop resulting 
in a “point of no return” which is suggested in this work. Alternatively, progressive 
fibrosis may be due to a lack of ability to resolve fibrosis possibly due to genetic 
predisposition or other secondary effects. Taking these possibilities into consideration 
future work should aim to explore 1) what is the key factor / factors in determining the 
“point of no return”? 2) How can recovery take place in a transient model? Specifically, 
what is able to interrupt the positive feedback loop characteristic of fibrosis demonstrated 
in this work? and 3) does the composition and state of the matrix change differently in 
transient vs. progressive models of fibrosis. Answers to these questions would provide 
 110 
significant additional information to the results provided in this dissertation, and taken 
together, provide promising new leads for treatment options for lung fibrosis.  
In conclusion, this dissertation shows for the first time that a fine balance between 
integrin specific engagements to Fn and substrate rigidity influences alveolar epithelial 
cell EMT, and that this balance can be shifted by additional injury events. The EMT 
observed due to the properties of the matrix are likely due to an increase in cell 
contractility, resulting in TGFβ activation, while exposure to PM2.5 results in additional 
TGFβ activation through increased levels of ROS. This work highlights that EMT is a 
complicated process resulting from changes in the biochemical and biophysical properties 
of the surrounding ECM as well as external stimuli. Additionally, it is shown that there is 
likely a certain threshold of pro-EMT signals that must be reached for ATII cells to 
undergo a transition, and that this threshold is not predominantly controlled by any single 
factor. However, this work suggests that these main drivers of EMT are interrelated and 
likely result in a strong positive feedback loop of pro-fibrotic signals leading to the severe 
progression of pulmonary fibrosis. Therefore, new potential treatments should focus on 
the interaction between the multiple drivers of EMT in order to interrupt this feedback 
loop. Finally, the findings that show that integrin specific engagement is able to drive 
differential ATII cell phenotypes on a single matrix rigidity offer the potential for new 
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